Reimbursement Of Health Care By Medical. Insurance Market ". For The 2. Mid-2001

Original Language Title: úhrady zdravotní péče hrazené ze zdravot. pojiš. pro 2. pol. 2001

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$20 per month, or Get a Day Pass for only USD$4.99.
211/2001 Sb.



DECREE



The Ministry of health



of 15 November 2004. June 2001,



laying down the amount of reimbursement of health care covered by the public

health insurance, including regulatory restrictions for 2. half-year 2001



The Ministry of health shall lay down pursuant to § 17 para. 11 (a). (b)) of the Act

No. 48/1997 Coll., on public health insurance and amending and supplementing

some related laws, as amended by Act No. 458/2000 Coll., (hereinafter referred to

"the Act"):



§ 1



This Decree lays down the



and the amount of the reimbursement) of health care paid for by public health insurance

including the regulatory restrictions for 2. half of 2001 for health care in the

Health residential care, including specialist treatment

institutes for long-term patients, hospitals and medical facilities

returning the treatment day no. 00005 according to the Decree, which shall be issued

list of medical procedures with point values in "^ 1") (hereinafter referred to as "list

performance "),



(b) the amount of the reimbursement) when providing emergency care in non-Contracting

health-care facilities.



§ 2



(1) health care provided in health establishments of the constitutional

care, with the exception of health care in specialised therapeutic institutes,

institutes for long-term patients and in medical devices

returning the treatment day no. 00005 according to the list of performances (hereinafter referred to as

"inpatient facilities"), 2. half of 2001, according to the contract shall be borne by

the arrangement between the health insurance company and fasility



flat rate),



(b)) according to the list of performances, or



c) at the request of post operative care facilities combined in an agreed manner of payment

with the payment for the diagnosis.



(2) a different payment method than the one referred to in paragraph 1, it is possible, if

the total amount of the payment will be higher than the remuneration provided for in paragraph 1

(a). and) or (b)) and inpatient facilities, and the health insurance fund on the proposal for a

Socket device on such a method of payment agreed.



(3) the procedure for calculating the flat-rate amount and conditions for reimbursement under

paragraph 1 (b). a) and b) are set out in annex 1 to this notice.



(4) price point for the payment of health care referred to in paragraph 1 (b). (b))

set for 1. half of 2001 remains in force for 2. half-year

2001. ^ 2)



(5) the amount of remuneration referred to in paragraph 1 (b). (c)) shall negotiate in the contract between

health insurance and, with the amount of fasility payment

the provision of acute care will be established to pay for diagnosis and

other health care will be covered by a flat rate.



(6) If an inpatient facility and health insurance fund shall conclude an addendum to the

contract or agree a new contract containing new medical procedures

provided by fasility, or agree on a new structure

health care is provided by the health insurance fund shall be bound to these

fact, to the total amount of payments for 2. half of 2001 include.



(7) If in the 2. half of 2001 income from a selection of premium

one of the insured person is higher than the approved health insurance plan provides for

health insurance for the year 2001, will increase the health insurance company

the total amount of the payment provided for in annex 1 of this order so much

how much per mille Mille has increased the selection of one

than the amount stated in the insured's health insurance plan. As follows

the calculated increase in remuneration is multiplied by the number of 0.9. This increase in pay

health insurance lůžkovému devices until 31 December 2006. May 2002.



(8) if payment of a flat rate referred to in paragraph 1 (b). and)

health insurance provides beyond the flat rate at 2. half-year

2001, particularly the payment of



and for kardiovertry and later) for cardiac pacemakers, including electrodes,

provided in the case of reimplantací (performances no 55217 and 55219 referred to in

list of performances), which were provided in a 2. half-year 2001



(b)) for the neuromodulační enhancers that have been provided in a 2. half-year

2001 in the treatment of epilepsy and Parkinson's disease,



(c)) for the neuromodulační enhancers and intrathekální pump provided by

treatment of chronic painful conditions. half of 2001 in the bed

the establishments listed in Appendix 3 to this Decree [peripheral nerve

stimulation (PNS), stimulation of the spinal cord or the rear roots (SCS)

deep brain stimulation, and korová for the promoters of the front corners

Spinal (SARS) for transversálních lesions of spinal cord injury]; inpatient facilities

referred to in annex 3 to this Ordinance may apply to the sum of the

health insurance in the Czech Republic up to 30 programmable

prostheses,



(d)) for the treatment of in vitro fertilization, which was granted in 2. half-year

2001-bed devices implementing the standard treatment of sterility

the method of fertilization, discontinued



e) medical procedures of hemodialysis No. 18051, 18052, 18510, 18513,

18521, 18522, 18530, 18550, 18560, 18570, and 18590 18580 by list

the performances, which were provided in a 2. half of 2001, with the price point

for the payment of such performances fixed for 1. half year 2001 shall remain in

valid for 2. half year 2001; ^ 3) for # 18521 medical procedures,

18522, 18530, 18550, 18560, 18570, 18580 and 18590, referred to in the notice,

down overhead costs in the amount of 4 points per minute,



f) posted a particularly medicinal products for the treatment of hemophilia, referred to in

Annex No 4 to this Decree, granted 2. half of 2001 in the

inpatient facilities,



(g)) of a particularly charged to medicines for the treatment of HIV/AIDS

(antiretroviral medicines and medicines for complex

treatment of opportunistic infections) provided in the 2. half of 2001 in the bed

the establishments listed in Appendix 5 to this Decree; antiretroviral

medicinal products and medicinal products for comprehensive treatment of opportunistic

infections are listed in Appendix 6 to this Ordinance,



(h)) to be particularly charged medicine Cerezyme, to treat disease

Morbus Gaucher, provided only the clinic of child and adolescent

medicine General faculty hospital in Prague 2. half-year 2001



I) per treatment days resuscitation and intensive care no 00051 00052,,

00053, 00055, 00057, 00058, 00061, 00065, 00068 according to the list of performances

provided in the treatment of extensive burns in the 2. half of the year 2001, in

inpatient facilities referred to in annex 7 to this Decree, and

the price point for the payment of such performances fixed for 1. half-year 2001

remains valid for 2. half year 2001, ^ 4)



(j)) of a particularly charged medicines provided in the 2. half-year 2001

in the treatment of cystic fibrosis in the bed devices listed in annex No.

8 to this Ordinance; the list of medicinal products is charged separately

listed in Appendix 9 to this Decree,



separately charged to) for medicinal products granted in 2. half of 2001 for

Oncology children treated with children's Oncology at the workplace

bed care establishments listed in annex 10 to this Decree; for a list of

separately charged to medicinal products is given in annex 11 to this

the Decree.



§ 3



(1) the health care provided by specialised therapeutic institutes in 2.

half of 2001 shall be borne by by a contractual arrangement between the health insurance company

and expert medical Institute



a) flat rate, or



(b)) combined way according to annex 2 of part B).



(2) a different payment method than the one referred to in paragraph 1, it is possible, if

the total amount of the payment will be higher than the remuneration provided for in paragraph 1

(a). a) or (b)) and the Professional Institute of therapeutic and health insurance at

design of vocational medical facility on this method of payment agreed.



(3) the procedure for calculation and payment of the flat-rate combined way, above

and conditions for reimbursement referred to in paragraph 1 (b). a) and b) are set out in the annex

No 2 to this Decree.



(4) price point for the payment of health care referred to in paragraph 1 (b). (b))

set for 1. half of 2001 remains in force for 2. half-year

2001. ^ 5)



(5) If a specialist clinic and the health insurance fund shall conclude an addendum

to the contract or agree on a new contract containing new health

performances, provided by professional medical Institute, or agree to pay a new

the structure of the health care provided by the health insurance fund is required to

These facts in the total amount of payments for 2. half of 2001 include.



§ 4



(1) health care provided in hospitals for long-term patients in

2. half 2001 paid pursuant to a contractual arrangement between the health

insurance and medical facilities, according to a list of performances.



(2) a different payment method than the one referred to in paragraph 1, it is possible, if

the total amount of the payment will be higher than the remuneration provided for in paragraph 1 and

Sanatorium and health insurance company on the design of the hospital

for long-term patients on this method of payment agreed.



(3) the price point for the payment of health care referred to in paragraph 1 provided for the

1. half-year 2001 remains in force for 2. half year 2001. ^ 6)



(4) the value of the agreed contract with overhead health insurance,

assigned to the point value of the treatment of the day # 00024 referred to in

list of performances, increased by 60 points compared with 2. half of the year 2000.



(5) lump-sum amount that is payable under section 17 of the medicinal products, para.

12 of the law, increases by $ 10 compared to 2. half of the year 2000.



§ 5




(1) health care provided in health facilities

returning the treatment day no. 00005 referred to in the list of performances in the 2.

half of 2001 shall be borne by by a contractual arrangement between the health insurance company

and medical facilities, according to a list of performances.



(2) a different payment method than the one referred to in paragraph 1, it is possible, if

the total amount of the payment will be higher than the remuneration provided for in paragraph 1 and

medical facilities and health insurance to the health care proposal

device on such a method of payment agreed.



(3) the price point for the payment of health care referred to in paragraph 1 provided for the

1. half-year 2001 remains in force for 2. half year 2001. ^ 7)



(4) the value of the agreed contract with overhead health insurance,

assigned to the point value of the treatment of the day no. 00005 referred to in

list of performances, increased by 60 points compared with 2. half of the year 2000.



(5) lump-sum amount that is payable under section 17 of the medicinal products, para.

12 of the law, increases by $ 10 compared to 2. half of the year 2000.



§ 6



(1) the reimbursement of emergency health care, if there is no contract between the

medical facilities and health insurance company, is in the 2. half-year 2001

performed medical procedures provided as follows:



and) dental out-patient care are reimbursed according to the rates applicable to

healthcare provided by dentists. half-year 2001



(b)) other health care are to be paid according to the list of performance and health

the undertaking may, on the basis of the law ^ 8) apply regulatory mechanisms

as with the contracted medical facilities.



(2) price point for the payment of health care referred to in paragraph 1 (b). (b))

set for 1. half of 2001 remains in force for 2. half-year

2001. ^ 9)



§ 7



This Decree shall enter into force on 1 January 2000. July 2001.



Minister:



Prof. MUDr. Fiser, CSc. v. r.



Č. 1



Procedure for calculating the flat-rate, amount and conditions for reimbursement pursuant to § 2 (2). 1

(a). a) and b)



And)



Procedure for determining the reimbursement at a flat rate:



1. Reimbursement of health care provided by the bed devices includes:



and acute care reimbursement) reported on hospitalizačních accounts

including relevant performance complement (hereinafter referred to as "hospital

reimbursement "),



(b)) reimbursement of out-patient ambulatory care reporting on accounts, including

the relevant performance complement (hereinafter referred to as "ambulatory payment"),



(c) the payment of health transport performance) (hereinafter referred to as "traffic payment"),



(d) the payment of the other outputs) of health care, if the bed device

provides performance complement for other medical institutions, where appropriate,

other contracted performances (hereinafter referred to as "other remuneration").



If any of the above types of inpatient health care facility

does not, then it is not part of the remuneration.



2. the procedure of a flat rate for 1. half of 2001: flat rate is calculated

for each type of health care referred to in paragraph 1 (b). a) to (d))

the volume of outputs for 2. half of 2000 that were fasility

reported and health insurance are recognised from 1. July 2000 to 31 December 2006.

in May 2001, as follows:



The total volume of performances (especially the points charged to medicines and separately

posted material) is divided by the number of unique treated insured persons,

who have been in the bed device provided health care. Unique

treated by the insured person means one insured person regardless,

the number of times the device reported on this bed of the insured person in a specified

period of health care. Performances and unique treatment of the insured person is

be calculated separately for each type of payment in accordance with point 1 (b). a) to (d)).



The flat rate includes:



and the number of points per 1) unique treated the insured person,



(b)) a flat rate for a particularly charged medicines and separately billed

the material on 1 unique treated the insured person in CZK,



2.1 the flat rate includes

sum sum BH ZH

PHB = --------- PHZ = --------

sum of the sum of the UH UH



where:



Ph = dots per 1 unique treated the insured's 2. half-year

2000



BH = number of points for all of the medical procedures when

hospitalisation, including points for the category of patient by 2. half-year 2000

the post operative care facilities that were reported and fasility

health insurance company recognized by 1. July 2000 to 31 December 2006. in May 2001,

In addition to the points:



and paid for medical procedures). half of 2001 in excess of the flat-rate

the rates of inpatient or included in the other flat-rate,



(b)) for the declared and recognized by the medical procedures provided during hospitalization in

skills that are no longer for 2. half of 2001 contracted.



PHZ = flat rate for a particularly charged medicines and separately

posted material provided in 2. half of 2000 to hospitalized

insurance policy holders on 1 unique treated the insured person.



ZH = payment for separately charged medicines and separately billed

material provided in 2. half of the year 2000, the insured hospitalized

that was reported by the fasility and health insurance company, has been recognized by

1 July 2000 to 31 December 2006. May 2001, in addition to the separately posted material

and separately charged of medicinal products:



and paid in 2.) half of 2001 beyond the flat rate

inpatient or included in the other flat-rate,



(b)) provided during the hospitalization in skills that are no longer for

2. half 2001 contracted.



UH = the number of unique treated insured persons, who have been in the 2. half-year

2000 hospitalized and their medical procedures have been provided by

the device reported and health insurance are recognised from 1. July 2000

until 31 December 2006. May 2001.



2.2 the flat rate for outpatient

sum sum for BA

PAB = --------- PAZ = --------

sum of the sum of UA UA



where:



PAB = dots per 1 unique treated the insured's 2. half-year

2000.



BA = number of points for all of the medical procedures in the out-patient clinics,

2. half of 2000 that were reported and fasility health

insurance recognised from 1. July 2000 to 31 December 2006. in May 2001, in addition to the points:



and paid for medical procedures). half of 2001 in excess of the flat-rate

rates of outpatient or included in the other flat-rate,



(b)) for the declared and recognized by the medical procedures provided in out-patient clinics in

skills that are no longer for 2. half of 2001 contracted.



PAZ = flat rate for a particularly charged medicines and separately

posted material provided in 2. half of the year 2000 in the out-patient clinics

treated to the insured on 1 unique treated the insured person.



A = remuneration for the separately charged medicines and separately billed

material provided in 2. half of the year 2000 in the out-patient clinics treated

the insured, who was banished and fasility health

the insurance company accepted from 1. July 2000 to 31 December 2006. May 2001, in addition to separately

the posted material and separately charged of medicinal products:



and paid in 2.) half of 2001 beyond the flat rate for outpatient

or included in the other flat-rate,



(b)) provided in the out-patient clinics in the specializations that are no longer for 2.

half of 2001 contracted.



UA = the number of unique treated insured persons, who have been in the 2. half-year

2000 in the out-patient clinics treated and they provided medical procedures that

were reported and fasility health insurance recognised from 1.

July 2000 to 31 December 2006. May 2001.



3. A flat rate per medical transport

sum sum BD ZD

PDB = --------- PDZ = --------

sum sum UD UD



where:



PDB = dots per 1 unique treated the insured's 2. half-year

2000



BD = number of points for all of the medical procedures in health

transport in the 2. half of the year 2000 of the post operative care facilities that were

fasility reported and health insurance are recognised from 1.

July 2000 to 31 December 2006. in May 2001, in addition to the points:



and paid for medical procedures). half of 2001 in excess of the flat-rate

rates for medical transport or included in the other flat-rate,



(b)) for the declared and recognized by the medical procedures provided in health

transport, that are no longer for 2. half of 2001 contracted.



PDZ = flat rate for a particularly charged medicines and separately

posted material provided in 2. half of the year 2000 in the medical transport

transported or treated the insured on 1 unique treated

of the insured person.



ZD = payment for separately charged medicines and separately billed

material provided in 2. half of the year 2000 in the medical transport

transported or treated the insured, who was patient

the device recorded and recognised health insurance from 1. July 2000 to

May 31, 2001, in addition to the separately posted material and separately charged

medicinal products:



and paid in 2.) half of 2001 beyond the flat rate for health

transport or included in the other flat-rate,



(b)) was provided when the performances in the medical transport, which are not for 2.

half of 2001 contracted.



UD = the number of unique treated insured persons, who have been in the 2. half-year

2000 in the medical transport, transported, cared for them and, where appropriate,

medical procedures were reported and fasility


health insurance company recognized by 1. July 2000 to 31 December 2006. May 2001.



2.4 the flat rate for other medical procedures

sum sum REV. BJ

PJB = --------- PJZ = -------

sum sum UJ UJ



where:



PJB = dots per 1 unique treated the insured's 2. half-year

2000



BJ = number of points for all other medical procedures provided in 2.

half of the year 2000 of the post operative care facilities that were fasility

reported and health insurance are recognised from 1. July 2000 to 31 December 2006.

in May 2001, in addition to the points:



and paid for medical procedures). half of 2001 in excess of the flat-rate

the rates for other medical procedures or included in the other flat-rate,



(b)) in the reported and recognized by other medical procedures provided in

skills that are no longer for 2. half of 2001 contracted.



PJZ = flat rate for a particularly charged medicines and separately

posted material provided in 2. half of the year 2000, when other health

performance treated insureds 1 unique treated the insured person.



ZJ = payment for separately charged medicines and separately billed

material provided in 2. half of the year 2000, when other medical procedures

treated the insured, who was banished and fasility health

the insurance company accepted from 1. July 2000 to 31 December 2006. May 2001, in addition to separately

the posted material and separately charged of medicinal products:



and paid in excess of the flat-rate) rate for other medical procedures or

included in the other flat-rate,



(b)) was provided when other medical procedures in the fields of medicine, which

are no longer for 2. half of 2001 contracted.



UJ = the number of unique treated insured persons, who have been in the 2. half-year

2000 receiving other medical procedures that were fasility

reported and health insurance are recognised from 1. July 2000 to 31 December 2006.

May 2001.



3. The calculation of the lump-sum payment of 1 point in the calculation of lump-sum

payment for 1 point is based on the individual amount of remuneration for the 1 point in 2.

half of the year 2000, which modifies a differentiated increase in remuneration 3

bands (according to section 3.2).



3.1 an individual amount of remuneration for the 1 point (IVUB) 2. half-year 2000

represents the proportion of the total remuneration without separately charged to medicinal

products and separately charged material on 1 point. Shall be determined in accordance with

the following formula:

the sum of URÚHRADA2.pol. 2000-URZ2.pol. 2000

2. pol IVUB. 2000 =--------------------------------------

the sum of URBODY2.pol. 2000



where:



URÚHRADA2.pol. 2000 = remuneration for all medical procedures,

including categories of patient, provided by fasility in 2.

half of 2000 that were reported and recognised from 1. July 2000 to 31 December 2006.

May 2001; This payment will not count towards medical procedures that

they are in the 2. half of 2001 paid in excess of the flat-rate.



URZ2.pol. 2000 = payment for separately charged medicines and separately

the posted material, in addition to the separately charged of medicinal products and

the posted material, paid in excess of the flat-rate, provided

in the 2. half of 2000 that were reported and fasility health

insurance recognised from 1. July 2000 to 31 December 2006. May 2001.



URBODY2.pol. 2000 = the number of medical procedures and under category

the patient provided by fasility in 2. half of the year 2000, which

were reported and fasility health insurance recognised from 1.

July 2000 to 31 December 2006. May 2001; These points do not count towards the points

for medical procedures, which are in the 2. half of 2001 paid in excess of the

the flat rate.



3.2 the lump-sum payment for 1 point (PUB) for 2. half of 2001 is based on the

individual amount of remuneration for 1 point, detected in 2. half of the year 2000.

Shall be determined as follows:



If the calculated IVUB) is less than $, 0.89 PUB for 2.

half of 2001 is $, 0.89



(b)) if the calculated IVUB is equal to or less than or equal to 0.89 0.99 Eur,

added to this IVUB 0.01 € (PUB = IVUB + 0.01)



(c)) if the calculated IVUB is equal to or higher than CZK 1, the

computed IVUB (PUB = IVUB).



4. the calculation of the total payment for the health care



4.1 the flat-rate remuneration for each type of health care referred to in section 1

(a). and) to d) on 1 unique treated the insured person is made up of

by multiplying the number of dots per 1 unique flat-rate insured person treated

remuneration for 1 point (PUB) and by adding the volume of flat rate, particularly

posted medicines and separately charged materials paid for 1

unique treated the insured person.



The calculation of the lump-sum payment on 1 unique treated the insured's

different types of health care referred to in point 1 (b). a) to (d)) for 2.

half of 2001 is as follows:



PHU = (PHB x PUB) + PHZ



PAU = (PAB x PUB) + PAZ



PDU = (PDB x PUB) + PDZ



PJU = (PJD x PUB) + PJZ



where:



PHU = lump sum payment on 1 unique inpatient treated

of the insured person



PAU = lump sum payment for outpatient 1 unique treated the insured person



PDU = flat-rate remuneration of transport on 1 unique treated the insured person



PJU = lump sum payment to 1 other unique treated the insured person



4.2 remuneration for each type of health care referred to in point 1 (b). a) to

(d)) shall be calculated so that the flat-rate payment on 1 unique treated

the insured person shall be multiplied by the number of unique treated policyholders in

the reporting period as follows:



Hu = PHX x UHV



Au = PAC x UAV



DU = PDC x UDV



JU = PJC x UJV



where:



Hu = inpatient reimbursement



Au = outpatient reimbursement



DU = transportation reimbursement



JU = other charge



UHV = the number of inpatients treated policyholders facing unique

health care was reported in 2. half of 2001 and recognised

health insurance company



UAV = the number of unique treated policyholders who were ambulatory

health care, reported in 2. half of 2001 and recognised

health insurance company



UDV = the number of unique treated policyholders who have been health

to the right is granted, reported in 2. half of 2001 and recognised health

the insurance company



UJV = the number of unique treated policyholders who were other performances

provided, are shown at 2. half of 2001 and recognised health insurance



4.3 the total remuneration (CU) is the sum of the individual types of payments:



CU = HU + AU + DU + JU



Part of the total remuneration are on payment procedures under section 2 (2). 6 of this

the Decree.



5. Calculation of the remuneration in the regulation of prescription medicinal products, and

medical devices: when calculating the total reimbursement of health care

referred to in point 4.3, also apply regulatory mechanisms that are

based on a comparison of the average remuneration for prescribed medicines and

medical devices to 1 out of 2 treated the insured person. half of

2000 and 2. half of 2001. The comparison excludes medicinal products and

the review by a doctor-approved medical devices.



5.1 in the event that the average payment for prescribed medicines and

medical devices to 1 in 2. insured person treated half-year 2001

In addition to medicinal products and medical devices approved by the

the review by a doctor, exceeds 102% of the average of the reference remuneration, which is

made up of remuneration for prescribed medicines and medical

resources on 1 of the insured person on the 2nd treated half of the year 2000, it will be

Fixed crash in the amount of 60% of the total exceeded, which is calculated

as a product of the treated number of insured persons in a given period and the amount of

exceeding the cost of medicinal products and medical devices to 1

treated the insured compared to 102% of the average of the reference remuneration for medicinal

medicines and medical devices to 1 treated the insured person.



5.2 If the average payment for prescribed medicines, medical

resources on 1 of the insured person on the 2nd treated half of 2001 has reached 102

% of the average of the reference remuneration, which is made up of remuneration for prescribed

medicines and medical devices to 1 treated the insured person

in the 2. half of the year 2000, in addition to medicinal products and medical

the review of the funds approved by the doctor, the remuneration for the 2. half-year

2001 increased by 40% savings. This saving is calculated as

the product of the treated number of insured persons in a given period and the level of under-execution

the cost of medicines and medical devices to 1 treated

the insured person, compared to 102% of the average of the reference remuneration for medicinal products

and medical devices to 1 treated the insured person.



6. the provision of monthly advances health insurance company will provide in-patient

device monthly deposit of 106% one sixth volume of payment that

This lůžkovému devices were recovered at the 2. half of the year 2000.



(B))



When determining the remuneration referred to in the list of performances



1. Way of payment pursuant to § 2 (2). 1 (b). (b)) can only be redeemed at the

-bed facility where the provided volume significantly fluctuating health

care paid for by public health insurance, where it is not possible to determine the

flat rate over the reference period because of the small number of treated

the health insurance companies and the insured where inpatient facilities in


average of one health insurance company shall not charge more than 300 000 CZK

calendar quarter.



2. If the Contracting Parties agree, this variant can also select in the

the case of higher volume of the Bill, however, must be met

fluctuating volume of provided health care.



Č. 2



Procedure for calculating the flat-rate remuneration and combined way, above and

conditions for reimbursement pursuant to § 3 (2). 1 (b). a) and b)



And)



Procedure for determining the flat-rate payment for health care



Remuneration is 110% of the comparison of the volume of payments. Matching the volume of payment

is equal to the payment for health care provided in the corresponding 2.

half of the year 2000, declared and recognised from 1. July 2000 to 31 December 2006. may

2001, while in comparison the volume does not include remuneration for the

provided health care in the comparative period in cases where the

care is no longer in the professional treatment of the Institute is provided, or is paid

otherwise.



1. payment in the amount of 110% of the participants only on condition that the reported number of

in 2 days of treatment. half of 2001 is at least 95% of the number of

treatment days reported in 2. half of the year 2000. In the case that professional

Clinic reports less than 95% of these set of treatment days,

will be provided for the total rate for 2. half of 2001 for a bed

care has been reduced by a percentage which was not filled with the limit of the number of

treatment days.



2. the calculation of the remuneration in the regulation of prescription medicinal products, and

medical devices:



2.1. In the case that the average payment for prescribed medicines and

medical devices to 1 in 2. insured person treated half-year 2001

In addition to medicinal products and medical devices approved by the

the review by a doctor, exceeds 102% of the average of the reference remuneration, which is

made up of remuneration for prescribed medicines and medical

resources on 1 of the insured person on the 2nd treated half of the year 2000, it will be

Fixed crash in the amount of 60% of the total exceeded, which is calculated

as a product of the treated number of insured persons in a given period and the amount of

exceeding the cost of medicinal products and medical devices to 1

treated the insured compared to 102% of the average of the reference remuneration for medicinal

medicines and medical devices to 1 treated the insured person.



2.2 If the average payment for prescribed medicines, medical

resources on 1 of the insured person on the 2nd treated half of 2001 has reached 102

% of the average of the reference remuneration, which is made up of remuneration for prescribed

medicines and medical devices to 1 treated the insured person

in the 2. half of the year 2000, in addition to medicinal products and medical

the review of the funds approved by the doctor, the remuneration for the 2. half-year

2001 increased by 40% savings. This saving is calculated as

the product of the treated number of insured persons in a given period and the level of under-execution

the cost of medicines and medical devices to 1 treated

the insured person, compared to 102% of the average of the reference remuneration for medicinal products

and medical devices to 1 treated the insured person.



(B))



When remuneration combined way:



A combined method of payment will be used for specialized therapeutic institutes, which

inpatient care have only contracted medical procedures of treatment

day, or performances, which show the receipt and discharge

examination of the list of performances.



1. Inpatient care will be covered by the payment per treatment day and for performances,

which show the receipt and discharge examination referred to in the list

performances.



2. Out-patient care, medical transportation and other medical procedures will be

paid a flat rate. The flat rate is calculated from the volume of outputs for 2.

half of the year 2000, which specialised therapeutic institutes had been reported and

health insurance company recognized by 1. July 2000 to 31 December 2006. in May 2001,

as follows:



The total volume of medical procedures (points and separately charged to healing

preparations and posted material) is divided by the number of unique

insured persons who have been treated in the specialized treatment institution provided

health care. Unique treated the insured person means one

the insured person, regardless of how many times a specialist clinic has reported on

of the insured person within a specified time period of health care. Performances and

a unique treatment of insured persons shall be calculated separately for outpatient care,

medical transport and other medical procedures.



The flat rate includes:



and the number of points per 1) unique treated the insured person,



(b)) a flat rate for a particularly charged medicines and separately billed

material on 1 unique treated the insured person in CZK.



2.1 flat rate for outpatient

sum sum for BA

PAB = --------- PAZ = -------

sum of the sum of UA UA



PAB = dots per 1 unique treated the insured's 2. half-year

2000



BA = number of points for all of the medical procedures in the out-patient clinics in the

2. half of the year 2000 the vocational medical facility reported

and recognised from 1. July 2000 to 31 December 2006. in May 2001, in addition to the points:



and paid for medical procedures). half of 2001 in excess of the flat-rate

rates of outpatient or included in the other flat-rate,



(b)) for the declared and recognized by the medical procedures provided in out-patient clinics in

skills that are no longer for 2. half of 2001 contracted.



PAZ = flat rate for a particularly charged medicines and separately

posted material provided in 2. half of the year 2000 in the out-patient clinics

treated to the insured on 1 unique treated the insured person.



A = remuneration for the separately charged medicines and separately billed

material provided in 2. half of 2001 in the out-patient clinics treated

the insured, who was banished and recognised from 1. July 2000 to 31 December 2006.

May 2001, in addition to the separately posted material and separately charged

medicinal products:



and paid in 2.) half of 2001 beyond the flat rate for outpatient

or included in the other flat-rate,



(b)) provided in the out-patient clinics in the specializations that are no longer for 2.

half of 2001 contracted.



UA = the number of unique treated insured persons, who have been in the 2. half-year

2000 in the out-patient clinics and medical treatment procedures were reported and recognized

from the 1. July 2000 to 31 December 2006. May 2001.



2.2 the flat rate for medical transport

sum sum BD ZD

PDB = --------- PDZ = -------

sum sum UD UD



where:



PDB = dots per 1 unique treated the insured's 2. half-year

2000



BD = number of points for all of the medical procedures in health

transport in the 2. half of 2000 the vocational medical facility that

were reported and recognised from 1. July 2000 to 31 December 2006. in May 2000, in addition to

points:



and paid for medical procedures). half of 2001 in excess of the flat-rate

rates for medical transport or included in the other flat-rate,



(b)) for the declared and recognized by the medical procedures provided in health

transport, that are no longer for 2. half of 2001 contracted.



PDZ = flat rate for a particularly charged medicines and separately

posted material provided in 2. half of the year 2000 in the medical transport

transported or treated the insured on 1 unique treated

of the insured person.



ZD = payment for separately charged medicines and separately billed

material provided in 2. half of the year 2000 in the medical transport

transported or treated the insured, who was banished and recognized

from the 1. July 2000 to 31 December 2006. May 2001, in addition to the separately posted

material and separately charged of medicinal products:



and paid in 2.) half of 2001 beyond the flat rate for health

transport or included in the other flat-rate,



(b)) was provided when the performances in the medical transport, that are no longer for

2. half 2001 contracted.



UD = the number of unique treated insured persons, who have been in the 2. half-year

2000 in the medical transport, transported, or treated and health

the performances were recorded and recognised from 1. July 2000 to 31 December 2006. May 2001.



2.3 the flat rate for other medical procedures

sum sum REV. BJ

PJB = --------- PJZ = -------

sum sum UJ UJ



where:



PJB = dots per 1 unique treated the insured's 2. half-year

2000



BJ = number of points for all other medical procedures provided in 2.

half of 2000 the vocational medical facility, that have been reported and

recognised from 1. July 2000 to 31 December 2006. in May 2001, in addition to the points:



and paid for medical procedures). half of 2001 in excess of the flat-rate

the rates for other medical procedures or included in the other flat-rate,



(b)) in the reported and recognized by other medical procedures provided in

skills that are no longer for 2. half of 2001 contracted.



PJZ = flat rate for a particularly charged medicines and separately

posted material provided in 2. half of the year 2000, when other health

performance treated insureds 1 unique treated the insured person.



ZJ = payment for separately charged medicines and separately billed

material provided in 2. half of the year 2000, when other medical procedures


treated the insured, who was banished and recognised from 1. July 2000 to

May 31, 2001, in addition to the separately posted material and separately charged

medicinal products:



and paid in excess of the flat-rate) rate for other medical procedures or

included in the other flat-rate,



(b)) was provided when other medical procedures in the fields of medicine, which

are no longer for 2. half of 2001 contracted.



UJ = the number of unique treated insured persons, who have been in the 2. half-year

2000 receiving other medical procedures that have been declared and recognised by

1 July 2000 to 31 December 2006. May 2001.



3. Calculation of the remuneration for the health care



The flat-rate payment for out-patient care, health services and other health

performances on 1 unique treated the insured person is formed by multiplying the

the number of dots per 1 unique flat-rate remuneration of an insured person for a treated 1

point and by adding the volume of flat rate for a particularly charged to healing

products and separately charged materials covered by 1 unique

treated the insured person.



3.1 calculation of the lump-sum payment on 1 unique treated the insured's

the different types of health care for 2. half of 2001 is as follows:



PAU = (PAB x CB) + PAZ



PDU = (PDB x CB) + PDZ



PJU = (PJB x CB) + PJZ



where:



PAU = lump sum payment per 1 outpatient unique treated the insured person



PDU = flat-rate remuneration of transport on 1 unique treated the insured person



PJU = lump sum payment to 1 other unique treated the insured person



CB = price point according to § 3 (2). 4 of this order



3.2 payment for out-patient care, health services and other health

performance is calculated so that the flat-rate payment shall be multiplied by the number of

unique treated policyholders in the reporting period as follows:



Au = PAU x UAV



DU = PDU x UDV



JU = PJU x UJV



where:



Au = outpatient reimbursement



DU = transportation reimbursement



JU = other charge



UAV = the number of unique treated policyholders who were ambulatory

health care, reported in 2. half of 2001 and recognised

health insurance company



UDV = the number of unique treated policyholders who have been health

to the right is granted, reported in 2. half of 2001 and recognised health

the insurance company



UJV = the number of unique treated insured persons, to whom the other performances

provided, are shown at 2. half of 2001 and recognised health insurance



3.3 total remuneration (CU) is the sum of outpatient payment (AU), transport

compensation (DU) and other remuneration (JU):



CU = AU + DU + JU



Part of the total remuneration are further payment procedures pursuant to § 3 (2). 4 this

the Decree.



4 calculation of the remuneration in the regulation of prescription medicinal products, and

medical devices:



To calculate the total payment of health care referred to in section 4 shall apply

regulatory mechanisms that are based on a comparison of the average of the remuneration

for prescribed medicines and medical devices to 1

treated the insured person between 2. half of 2000 and 2. half of 2001. From

the comparison excludes medicinal products and medical devices approved by the

the review by a doctor.



4.1 in the event that the average payment for prescribed medicines and

medical devices to 1 in 2. insured person treated half-year 2001

In addition to medicinal products and medical devices approved by the

the review by a doctor, exceeds 102% of the average of the reference remuneration, which is

made up of remuneration for prescribed medicines and medical

resources on 1 of the insured person on the 2nd treated half of the year 2000, it will be

Fixed crash in the amount of 60% of the total exceeded, which is calculated

as a product of the treated number of insured persons in a given period and the amount of

exceeding the cost of medicinal products and medical devices to 1

treated the insured compared to 102% of the average of the reference remuneration for medicinal

medicines and medical devices to 1 treated the insured person.



4.2 If the average payment for prescribed medicines, medical

resources on 1 of the insured person on the 2nd treated half of 2001 has reached 102

% of the average of the reference remuneration, which is made up of remuneration for prescribed

medicines and medical devices to 1 treated the insured person

in the 2. half of the year 2000, in addition to medicinal products and medical

the review of the funds approved by the doctor, the remuneration for the 2. half-year

2001 increased by 40% savings. This saving is calculated as

the product of the treated number of insured persons in the period and cost's

for medicinal products and medical devices to 1 treated

the insured person, compared to 102% of the average of the reference remuneration for medicinal products

and medical devices to 1 treated the insured person.



Č. 3



List of in-patient-center for the treatment of chronic pain

States

+--+--------+---------------------------------+---------+

| # | CORPORATE ID | The name of the post operative care | Head Office |

+--+--------+---------------------------------+---------+

| # 1 | 00023884 | Na Homolce Hospital | Prague 5 |

+--+--------+---------------------------------+---------+

| 2 | 00064203 | Teaching hospital in motol | Prague 5 |

+--+--------+---------------------------------+---------+

| # 3 | 61383082 | Central military hospital Prague | Prague 6 |

+--+--------+---------------------------------+---------+

| 4 | 00159816 | The University Hospital. Anna | Brno |

+--+--------+---------------------------------+---------+

| 5. | 65269705 | University Hospital Brno | Brno |

+--+--------+---------------------------------+---------+

| 6 | 00098892 | University Hospital Olomouc | Olomouc 5 |

+--+--------+---------------------------------+---------+



Č. 4



List of proprietary medicinal products for the treatment of hemophilia

+------------+-----+-----------------------------+--------------------+

| The active substance | Code | The name | The add-in name |

+------------+-----+-----------------------------+--------------------+

| Coagulation | 53360 | Antihem. F. (human), hemofil M | INJ SIC 1X1000UT + SAT |

|faktor VIII +-----+-----------------------------+--------------------+

| | 93006 | Antihem. F. (human), hemofil M | INJ SIC 1X250UT + SOL |

| +-----+-----------------------------+--------------------+

| | 53359 | Antihem. F. (human), hemofil M | INJ SIC 1X500UT + SOL |

| +-----+-----------------------------+--------------------+

| | 87240 | Fanhdi 1000 IU | INJ SIC 1X1KU + SOLV. |

| +-----+-----------------------------+--------------------+

| | 87238 | Fanhdi 250 IU | INJ SIC 1X250UT + SOL |

| +-----+-----------------------------+--------------------+

| | 87239 | Fanhdi 500 IU | INJ SIC 1X500UT + SOL |

| +-----+-----------------------------+--------------------+

| | 60381 | Haemoctin SDH 1000 | INJ SIC 1X1KU + SOLV. |

| +-----+-----------------------------+--------------------+

| | 60379 | Haemoctin SDH 250 | INJ SIC 1X1250 + SOL |

| +-----+-----------------------------+--------------------+

| | 60380 | Haemoctin SDH 500 | INJ SIC 1X1500 + SOL |

| +-----+-----------------------------+--------------------+

| | 89029 | Immunate stim plus 1000 | INJ SIC 1X1KU + SOLV. |

| +-----+-----------------------------+--------------------+

| | 89027 | Immunate stim plus 250 | INJ SIC 1X1250UT + SOL |

| +-----+-----------------------------+--------------------+

| | 89028 | Immunate stim plus 500 | INJ SIC 1X1500UT + SOL |

+------------+-----+-----------------------------+--------------------+

| Coagulation | 75080 | Immunine 1200 E. | INJ SIC 1.2 KU + 10 ml |

|faktor IX +-----+-----------------------------+--------------------+

| | 75079 | Immunine 600 I.E. | INJ SIC 1X600UT + 5 ml |

+------------+-----+-----------------------------+--------------------+

| Other | 83535 | MCT OIL | OLE 1X946ML |

| | | | |

| | | | |

| food | | | |

+------------+-----+-----------------------------+--------------------+



Č. 5



A list of selected device-bed center for the treatment of HIV/AIDS

+--+--------+------------------------+----------------+-------------------+

| # | CORPORATE ID | The name of the post operative care | Head Office | The workplace |

+--+--------+------------------------+----------------+-------------------+

| # 1 | 65269705 | University Hospital Brno | Brno-Bohunice | clinic infectious |

| | | | | diseases |

+--+--------+------------------------+----------------+-------------------+

| 2 | 00179906 | University Hospital | Hradec Králové | infective clinic |

+--+--------+------------------------+----------------+-------------------+

| # 3 | 00843989 | University Hospital | Ostrava-Poruba | clinic for treatment |

| | | first | infectious diseases | |

| | | | | & AIDS |

+--+--------+------------------------+----------------+-------------------+

| 4 | 00669806 | University Hospital | Pilsen | AIDS Center |

| | | | |-infectious clinics |

+--+--------+------------------------+----------------+-------------------+

| 5. | 00064211 | University Hospital | Prague 8 | AIDS Center |

| | | The NA bulovce hospital | |-infectious clinics |

+--+--------+------------------------+----------------+-------------------+

| 6 | 00673544 | Masaryk hospital | Ústí nad Labem | Department of portable |

| | | first | | diseases |


+--+--------+------------------------+----------------+-------------------+

| 7 | 00072711 | Hospital České Budějovice Czech | | infectious Department |

| | | Budějovice | | Hospital |

+--+--------+------------------------+----------------+-------------------+



Č. 6



Antiretroviral medicines and medicines for comprehensive treatment

opportunistic infections in HIV/AIDS

+------------+-----+-----------------------+--------------------+

| The active substance | Code | The name | The add-in |

+------------+-----+-----------------------+--------------------+

| tikarcilin | 93169 | Timentin 1.6 GM | INJ SIC 4 x 1.6 GM |

|a inhibitor +-----+-----------------------+--------------------+

| | 93170 enzyme | Timentin 3.2 GM | INJ SIC 4 x 3.2 GM |

+------------+-----+-----------------------+--------------------+

| piperacillin | 12336 | Pipraks | INJ SIC 1X2GM + 10 ml |

| +-----+-----------------------+--------------------+

| | 94251 | Pipril 2GM | INJ SIC 1X2GM |

| +-----+-----------------------+--------------------+

| | 58182 | Pipril 4GM | INJ SIC 1X4GM |

| +-----+-----------------------+--------------------+

| | 94252 | Pipril 4GM | INJ SIC 1X4GM |

+------------+-----+-----------------------+--------------------+

| | ceftazidim 55867 | Kefadim 1GM | INJ SIC 1X1GM |

| +-----+-----------------------+--------------------+

| | 55868 | Kefadim 2GM | INJ SIC 1X2GM |

| +-----+-----------------------+--------------------+

| | 76353 | Fortum | INJ SIC 1X1GM |

| +-----+-----------------------+--------------------+

| | 76354 | Fortum | INJ SIC 1X2GM |

| +-----+-----------------------+--------------------+

| | 76355 | Fortum | INJ SIC 1X500MG |

+------------+-----+-----------------------+--------------------+

| ceftriaxone | 53722 | Cefaxone 1000 mg | INJ SIC 1X1000MG |

| +-----+-----------------------+--------------------+

| | 83958 | Cefaxone 250 mg | INJ SIC 1X250MG |

| +-----+-----------------------+--------------------+

| | 53719 | Cefaxone 500 mg | INJ SIC 1X500MG |

| +-----+-----------------------+--------------------+

| | 01645 | Ceftriaxone-1000 SL | INJ SIC 5X1GM |

| +-----+-----------------------+--------------------+

| | 01649 | Ceftriaxone 2000-SL | INJ SIC 1X2GM |

| +-----+-----------------------+--------------------+

| | 01648 | Ceftriaxone 2000-SL | INJ SIC 5X2GM |

| +-----+-----------------------+--------------------+

| | 01647 | Ceftriaxone 500-SL | INJ SIC 5 x 0.5 GM |

| +-----+-----------------------+--------------------+

| | 80662 | Lendacin 1 g | INJ SIC 5X1GM |

| +-----+-----------------------+--------------------+

| | 93491 | Longaceph 1GM | INJ SIC 10X1GM |

| +-----+-----------------------+--------------------+

| | 93492 | Longaceph 1GM | INJ SIC 50X1GM |

| +-----+-----------------------+--------------------+

| | 93489 | Longaceph 250 mg | INJ SIC 10X250MG |

| +-----+-----------------------+--------------------+

| | 54086 | Novosef 1 g Im | INJ SIC 1X1GM + SOLV. |

| +-----+-----------------------+--------------------+

| | 54085 | Novosef 1 g Iv | INJ SIC 1X1GM + SOLV. |

+------------+-----+-----------------------+--------------------+

| cefoperazone | 75039 | Cefobid 1GM | INJ SIC 1X1GM |

+------------+-----+-----------------------+--------------------+

| cefepim | 87199 | Maxipime 1GM | INJ SIC 1X1GM |

| +-----+-----------------------+--------------------+

| | 87200 | Maxipime 2GM | INJ SIC 1X2GM |

| +-----+-----------------------+--------------------+

| | 87198 | Maxipime 500 mg | INJ SIC 1X500MG |

+------------+-----+-----------------------+--------------------+

| celpirom | 86597 | Cefrom 1GM | INJ SIC 1X1GM |

| +-----+-----------------------+--------------------+

| | 86699 | Cefrom 1GM | INJ SIC 1X1GM |

| +-----+-----------------------+--------------------+

| | 86598 | Cefrom 2GM | INJ SIC 1X2GM |

| +-----+-----------------------+--------------------+

| | 86700 | Cefrom 2GM | INJ SIC 1X2GM |

+------------+-----+-----------------------+--------------------+

| cefixim | 76233 | Suprax | TBL OBD 10X200MG |

| +-----+-----------------------+--------------------+

| | 76233 | Suprax | PLV SUS 1X50ML/1GM |

+------------+-----+-----------------------+--------------------+

| cefotaxime | 83955 | Cefantral 1GM | INJ SIC 1X1GM |

| +-----+-----------------------+--------------------+

| | 94176 | Cefotaxime lek 1GM | INJ SIC 1X1GM |

| +-----+-----------------------+--------------------+

| | 94177 | Cefotaxime lek 2GM | INJ SIC 1X2GM |

| +-----+-----------------------+--------------------+

| | 93715 | Claforan | INJ SIC 1X1GM |

| +-----+-----------------------+--------------------+

| | 11354 | Claforan | INJ SIC 1X1GM |

| | 1.0 G IV | I.M. | |

| +-----+-----------------------+--------------------+

| | 53235 | Sefotak 0.5 GM | INJ SIC 1 x 0.5 GM + SOL |

| +-----+-----------------------+--------------------+

| | 53236 | Sefotak 1GM | INJ SIC 1X1GM + SOLV. |

| +-----+-----------------------+--------------------+

| | 05770 | Taxcef | INJ SIC 1X1GM |

| +-----+-----------------------+--------------------+

| | 05768 | Taxcef | INJ SIC 1X500MG |

| +-----+-----------------------+--------------------+

| | 05748 | Taxcef 2 g | INJ SIC 1X2GM |

+------------+-----+-----------------------+--------------------+

| amoxicillin | 96415 | Antibiotics | GTT 1X20ML |

| +-----+-----------------------+--------------------+

| | 74991 | Antibiotics | PLV SUS 1X100ML |

| +-----+-----------------------+--------------------+

| | 72972 | Antibiotics for 1.2 GM | INJ SIC 5 x 1.2 GM |

| +-----+-----------------------+--------------------+

| | 05951 | Antibiotics for 1 g | TBL OBD 14X1GM |

| +-----+-----------------------+--------------------+

| | 85524 | Antibiotics for 375 mg | TBL OBD 21X375MG |

| +-----+-----------------------+--------------------+

| | 72973 | Antibiotics for 600 mg | INJ SIC 5X600MG |

| +-----+-----------------------+--------------------+

| | 85525 | Antibiotics for 625MG | TBL OBD 21X625MG |

| +-----+-----------------------+--------------------+

| | 96416 | Antibiotics for forte | PLV SUS 1X100ML/5 GM |

| +-----+-----------------------+--------------------+

| | 97660 | Augmentin 1.2 G | INJ SIC 5 x 1.2 GM |

| +-----+-----------------------+--------------------+

| | 66020 | Augmentin 1.2 GM | INJ SIC 10 x 1.2 GM |

| +-----+-----------------------+--------------------+

| | 92207 | Augmentin 1.2 GM | INJ SIC 5 x 1.2 GM |

| +-----+-----------------------+--------------------+

| | 91002 | Augmentin 156MG/5 ml | PLV SUS 1X100ML |

| +-----+-----------------------+--------------------+

| | 97658 | Augmentin 156MG/5 ml | SIR SIC 1X100ML |

| +-----+-----------------------+--------------------+

| | 12494 | Augmentin 1 g | TBL OBD 14X1GM |

| +-----+-----------------------+--------------------+

| | 53959 | Augmentin 1GM | TBL OBD 14X1GM |

| +-----+-----------------------+--------------------+

| | 96070 | Augmentin 312MG/5 ml | PLV SUS 1X100ML |

| +-----+-----------------------+--------------------+

| | 83739 | Augmentin 312MG/5 ml | SIR SIC 1X100ML |

| +-----+-----------------------+--------------------+

| | 93709 | Augmentin 375 mg | TBL OBD 21X375MG |

| +-----+-----------------------+--------------------+

| | 97657 | Augmentin 375 mg | TBL OBD 21X375MG |

| +-----+-----------------------+--------------------+

| | 92206 | Augmentin 600 mg | INJ SIC 10X600MG |

| +-----+-----------------------+--------------------+

| | 83738 | Augmentin 625MG | TBL OBD 21X625MG |

| +-----+-----------------------+--------------------+

| | 89852 | Augmentin 625MG | TBL OBD 21X625MG |

| +-----+-----------------------+--------------------+

| | 44793 | Augmentin Duo | PLV SUS 1X140ML |

| +-----+-----------------------+--------------------+

| | 84791 | Augmentin Duo | PLV SUS 1X35ML |

| +-----+-----------------------+--------------------+

| | 84792 | Augmentin Duo | PLV SUS 1X70ML |

| +-----+-----------------------+--------------------+

| | 53567 | Curam 156.25 MG/5 ml | PLV SUS 1X100ML |

| +-----+-----------------------+--------------------+

| | 53571 | Curam area 312.5 MG/5 ml | PLV SUS 1X100ML |

| +-----+-----------------------+--------------------+

| | 53577 | 625MG Curam | TBL OBD 21X625MG |

| +-----+-----------------------+--------------------+

| | 46093 | Enhancin 250/125 mg | TBL OBD 21X250MG |

| +-----+-----------------------+--------------------+

| | 46094 | Enhancin 500/125 mg | TBL OBD 21X500MG |

| +-----+-----------------------+--------------------+

| | 46710 | Klamoxin 625 | TBL OBD 16X500/125 mg |

| +-----+-----------------------+--------------------+

| | 59289 | Klamoxin 625 | TBL OBD 21X500/125 mg |

| +-----+-----------------------+--------------------+

| | 59290 | Klamoxin 625 | TBL OBD 30X500/125 mg |

+------------+-----+-----------------------+--------------------+

| + | cefoperazone 94756 | 2GM Sulperazon IM/IV | INJ SIC IX (1GM + 1GM) |

| sulbaktam | | | |

+------------+-----+-----------------------+--------------------+

| piperacillin | 84783 | Tazocin 2.25 GM | INJ SIC 1.2.25 GM |

|a enzymový +-----+-----------------------+--------------------+


| | 84784 inhibitor | Tazocin 4.5 GM | INJ SIC 1 4.0 GM |

+------------+-----+-----------------------+--------------------+

| aztreonam | 86412 | Azactam 1 g | INJ SIC 1X1GM |

+------------+-----+-----------------------+--------------------+

| meropenem | 83417 | Meronem | INJ SIC 10X1GM |

| +-----+-----------------------+--------------------+

| | 83487 | Meronem | INJ SIC 10X500MG |

+------------+-----+-----------------------+--------------------+

| lincomycin | 01835 | Lincocin | INJ 1X2ML/600 mg |

| +-----+-----------------------+--------------------+

| | 97565 | Neloren | INJ 10X2ML/600 mg |

| +-----+-----------------------+--------------------+

| | 91997 | Neloren | CPS 16X500MG |

+------------+-----+-----------------------+--------------------+

| clindamycin | 04234 | Dalacin C | INJ 1X2ML/300 mg |

| +-----+-----------------------+--------------------+

| | 08807 | Dalacin C | INJ 1X4ML/600 mg |

| +-----+-----------------------+--------------------+

| | 98212 | Dalacin C | INJ 3X6ML/900MG |

| +-----+-----------------------+--------------------+

| | 91193 | Dalacin C 150 mg | CPS 100X150MG |

| +-----+-----------------------+--------------------+

| | 03365 | Dalacin C 150 mg | CPS 16X150MG |

| +-----+-----------------------+--------------------+

| | 83458 | Dalacin C 300 mg | CPS 16X300MG |

| +-----+-----------------------+--------------------+

| | 97878 | Klimicin | INJ 10X2ML/300 mg |

| +-----+-----------------------+--------------------+

| | 64630 | Klimicin | INJ 10X4ML/600 mg |

| +-----+-----------------------+--------------------+

| | 94574 | Klimicin 150 mg | CPS 16X150MG |

| +-----+-----------------------+--------------------+

| | 56867 | Klimicin 300 mg | CPS 16X300MG |

+------------+-----+-----------------------+--------------------+

| netilmicin | 90485 | Netromycin 200 mg/2 ml | 1X2ML/INJ 200 mg |

| +-----+-----------------------+--------------------+

| | 83736 | Netromycin 400 mg/2 ml | INJ 1X2ML/400 mg |

| +-----+-----------------------+--------------------+

| | 76494 | Netromycin 50 mg/2 ml | 1X2ML/INJ 50 mg |

+------------+-----+-----------------------+--------------------+

| amikacin | 11785 | Amikin 1 g | INJ 1X4ML/1GM |

| +-----+-----------------------+--------------------+

| | 12334 | Amikozit 100 mg | INJ 1X2ML |

| +-----+-----------------------+--------------------+

| | 12335 | Amikozit 500 mg | INJ 1X2ML |

| +-----+-----------------------+--------------------+

| | 03951 | Amikin 100 mg | 1X2ML/INJ 100 mg |

| +-----+-----------------------+--------------------+

| | 03952 | Amikin 500 mg | 1X2ML/INJ 500 mg |

+------------+-----+-----------------------+--------------------+

| gentamicin | 55680 | Garamycin schwamm | SPN 1X130MG |

| +-----+-----------------------+--------------------+

| | 72970 | Gentamicin biochemistry | INJ 50X1ML/400 mg |

| | | 40 mg | |

| +-----+-----------------------+--------------------+

| | 72971 | Gentamicin biochemistry | INJ 50X2ML/80 mg |

| | | 80 mg | |

| +-----+-----------------------+--------------------+

| | 96413 | Gentamycin 40 mg/2 ml lek | INJ 10X2ML/40 mg |

| +-----+-----------------------+--------------------+

| | 96414 | Gentamicin 80 mg/2 ml lek | INJ 10X2ML/80 mg |

| +-----+-----------------------+--------------------+

| | 91138 | Septopal-10ER minikette | IMP 1X10KS |

| +-----+-----------------------+--------------------+

| | 91139 | Septopal-10ER minikette | IMP 5X10KS |

| +-----+-----------------------+--------------------+

| | 91145 | Septopal-20ER minikette | IMP 1X20KS |

| +-----+-----------------------+--------------------+

| | 91142 | Septopal-20ER minikette | IMP 5X20KS |

| +-----+-----------------------+--------------------+

| | 06195 | Septopal-30ER kette | IMP 1X30KD |

| +-----+-----------------------+--------------------+

| | 91140 | Septopal-30ER kette | IMP 5X30KS |

+------------+-----+-----------------------+--------------------+

| Vancomycin | 92289 | Edicin 0.5 GM | INJ SIC 1X500MG |

| +-----+-----------------------+--------------------+

| | 58375 | Vancoled | INJ SIC 1X500MG |

| +-----+-----------------------+--------------------+

| | 01619 | Vancocin CP 500 mg | INJ SIC 1X500MG |

| +-----+-----------------------+--------------------+

| | 58376 | Vancoled | INJ SIC 10X500MG |

| +-----+-----------------------+--------------------+

| | 92290 | Edicin 1GM | INJ SIC 1X1GM |

+------------+-----+-----------------------+--------------------+

| teicoplanin | 05114 | Targocid 200 mg | INJ SIC 1X200MG + SOL |

| +-----+-----------------------+--------------------+

| | 05113 | Targocid 400 mg | INJ SIC 1X400MG + SOL |

+------------+-----+-----------------------+--------------------+

|-| sulfameto 98100 | Berlocid 240 | SUS 1X100ML |

|xazol a +-----+-----------------------+--------------------+

| | trimetroprim 03378 | Biseptol 120 | TBL-BLI 20X120MG |

| +-----+-----------------------+--------------------+

| | 11706 | Biseptol 480 | INJ 10X5ML |

| +-----+-----------------------+--------------------+

| | 03377 | Biseptol 480 | TBL 20X480MG |

| +-----+-----------------------+--------------------+

| | 12917 | Bismoral 480 | TBL 20X480MG |

| +-----+-----------------------+--------------------+

| | 75022 | Cotrimoxazol al forte | TBL 10X960MG |

| +-----+-----------------------+--------------------+

| | 75023 | Cotrimoxazol al forte | TBL 20X960MG |

| +-----+-----------------------+--------------------+

| | 96417 | Nopil forte | TBL 10 |

| +-----+-----------------------+--------------------+

| | 99883 | Nopil for infant | SIR 1X100ML |

| +-----+-----------------------+--------------------+

| | 87758 | Oriprim | TBL 100X480MG |

| +-----+-----------------------+--------------------+

| | 97868 | Oriprim | TBL 20X480MG |

| +-----+-----------------------+--------------------+

| | 91281 | Primotren | INJ 10X5ML |

| +-----+-----------------------+--------------------+

| | 91291 | Sumetrolim | SIR 100 ml/5 ml 240 |

| +-----+-----------------------+--------------------+

| | 06264 | Sumetrolim | TBL 20X480MG |

+------------+-----+-----------------------+--------------------+

| ofloxacin | 66137 | Ofloxin inf | INF 1X100ML/200 mg |

| +-----+-----------------------+--------------------+

| | 12349 | Zanocin 200 mg | TBL OBD 10X200MG |

| +-----+-----------------------+--------------------+

| | 92740 | Tarivid Iv 200 | INF 5X100ML/200 mg |

| +-----+-----------------------+--------------------+

| | 54391 | Taroflox 200 | TBL OBD 10X200MG |

| +-----+-----------------------+--------------------+

| | 55636 | Ofloxin 200 | TBL OBD 10X200MG |

+------------+-----+-----------------------+--------------------+

| | pefloxacin 94155 | Abaktal | INJ 10X5ML/400 mg |

| +-----+-----------------------+--------------------+

| | 94156 | Abaktal | TBL OBD 10X400MG |

+------------+-----+-----------------------+--------------------+

|-| ciproflo 53715 | Cifloxinal | TBL OBD 200X250MG |

|xacin +-----+-----------------------+--------------------+

| | 53921 | Ciphin for infusione | INF 1X50ML/100 mg |

| | 100 mg/50 ml | | |

| +-----+-----------------------+--------------------+

| | 59829 | Ciprinol is 100 mg/50 ml | INF 1X50ML/100 mg |

| +-----+-----------------------+--------------------+

| | 59830 | Ciprinol 200 mg/100 ml | INF 1X100ML/200 mg |

| +-----+-----------------------+--------------------+

| | 69195 | Ciprobid 250 | TBL OBD 10X250MG |

| +-----+-----------------------+--------------------+

| | 69196 | Ciprobid 500 | TBL OBD 10X500MG |

| +-----+-----------------------+--------------------+

| | 64698 | Quintor 200 mg | TBL OBD 10X250MG |

| +-----+-----------------------+--------------------+

| | 80539 | Quintor 250 mg | TBL OBD 50X250MG |

| +-----+-----------------------+--------------------+

| | 64699 | Quintor 500 mg | TBL OBD 10X500MG |

| +-----+-----------------------+--------------------+

| | 80540 | Quintor 500 mg | TBL OBD 20X500MG |

| +-----+-----------------------+--------------------+

| | 96040 | Ciprinol 250 mg/10 ml | 5X10ML/INJ 100 mg |

| +-----+-----------------------+--------------------+

| | 94453 | Ciprinol 250 | TBL OBD 10X250MG |

| +-----+-----------------------+--------------------+

| | 96039 | Ciprinol 500 | TBL OBD 10X500MG |

| +-----+-----------------------+--------------------+

| | 56830 | Ciplox 200 mg/100 ml | INF 1X100ML (plastic) |

| +-----+-----------------------+--------------------+

| 44988 | | Ciplox 250 | TBL OBD 10X250MG |

| +-----+-----------------------+--------------------+

| | 44989 | Ciplox 250 | TBL OBD 50X250MG |

| +-----+-----------------------+--------------------+

| | 44985 | Ciplox 500 | TBL OBD 10X500MG |

| +-----+-----------------------+--------------------+

| | 44986 | Ciplox 500 | TBL OBD 50X500MG |

| +-----+-----------------------+--------------------+

| | 86636 | Ciprobay 100 | INF 5X50ML/100 mg |

| +-----+-----------------------+--------------------+

| | 86637 | Ciprobay 200 | INF 5X100ML/200 mg |

| +-----+-----------------------+--------------------+

| | 91155 | Ciprobay 250 | TBL OBD 10X250MG |


| +-----+-----------------------+--------------------+

| | 91156 | Ciprobay 500 | TBL OBD 10X500MG |

| +-----+-----------------------+--------------------+

| | 53201 | Ciphin 250 | TBL OBD 10X250MG |

| +-----+-----------------------+--------------------+

| | 53202 | Ciphin 500 | TBL OBD 10X500MG |

| +-----+-----------------------+--------------------+

| | 53203 | Ciphin 750 | TBL OBD 10X750MG |

| +-----+-----------------------+--------------------+

| | 53922 | Ciphin for infusion. | INF 1X100ML/200 mg |

| +-----+-----------------------+--------------------+

| | 87104 | Cifloxinal | TBL OBD 10X250MG |

| +-----+-----------------------+--------------------+

| | 87105 | Cifloxinal | TBL OBD 20X250MG |

+------------+-----+-----------------------+--------------------+

| fluconazole | 58431 | Diflazon | INF 1X100ML/200 mg |

| +-----+-----------------------+--------------------+

| | 59787 | Diflazon 100 | CPS 28X100MG |

| +-----+-----------------------+--------------------+

| | 59788 | Diflazon 150 | CPS 1X150MG |

| +-----+-----------------------+--------------------+

| | 59790 | Diflazon 200 | CPS 20X200MG |

| +-----+-----------------------+--------------------+

| | 59789 | Diflazon 200 | CPS 7X200MG |

| +-----+-----------------------+--------------------+

| | 59786 | Diflazon 50 | CPS 7X50MG |

| +-----+-----------------------+--------------------+

| | 53917 | Fluconazol 150-| CPS 1X150MG |

| | | Slovakofarma | |

| +-----+-----------------------+--------------------+

| | 53918 | Fluconazol 150-| CPS 2X150MG |

| | | Slovakofarma | |

| +-----+-----------------------+--------------------+

| | 53915 | Fluconazol 50-| CPS 10X50MG |

| | | Slovakofarma | |

| +-----+-----------------------+--------------------+

| | 55397 | Fluconazol 50-| CPS 14X50MG |

| | | Slovakofarma | |

| +-----+-----------------------+--------------------+

| | 53916 | Fluconazol 50-| CPS 20X50MG |

| | | Slovakofarma | |

| +-----+-----------------------+--------------------+

| | 55396 | Fluconazol 50-| CPS 7X50MG |

| | | Slovakofarma | |

| +-----+-----------------------+--------------------+

| | 46979 | Fluconazol | INF 1X100ML/200 mg |

| | | Slovakofarma for inf | |

| +-----+-----------------------+--------------------+

| | 66031 | SIR Mycomax | SIR 1X100ML/500 mg |

| +-----+-----------------------+--------------------+

| | 59872 | Mycosyst | INF 10X100ML 2 mg/ML |

| +-----+-----------------------+--------------------+

| | 59871 | Mycosyst | INF 1X100ML 2 mg/ML |

| +-----+-----------------------+--------------------+

| | 59874 | Mycosyst 100 MG | CPS 28X100MG |

| +-----+-----------------------+--------------------+

| | 59875 | Mycosyst 150 MG | CPS 1X150MG |

| +-----+-----------------------+--------------------+

| | 59876 | Mycosyst 150 MG | CPS 2X150MG |

| +-----+-----------------------+--------------------+

| | 10743 | Mycosyst 150 MG | CPS 4X150MG |

| +-----+-----------------------+--------------------+

| | 59873 | Mycosyst 50 MG | CPS 7X50MG |

| +-----+-----------------------+--------------------+

| | 64942 | Diflucan | CPS 28X100MG |

| +-----+-----------------------+--------------------+

| | 64940 | Diflucan | CPS 7X50MG |

| +-----+-----------------------+--------------------+

| | 64949 | Diflucan 200 mg/5 ml | PLV SUS 1X35ML |

| +-----+-----------------------+--------------------+

| | 64950 | Diflucan 50 mg/5 ml | PLV SUS 1X35ML |

| +-----+-----------------------+--------------------+

| | 64946 | Diflucan Iv | INF 1 x 100 ML 2 mg/ML |

| +-----+-----------------------+--------------------+

| | 66036 | Mycomax 100 | CPS 28X100MG |

| +-----+-----------------------+--------------------+

| | 66037 | Mycomax 100 | CPS 7X100MG |

| +-----+-----------------------+--------------------+

| | 66039 | Mycomax 150 | CPS 1X150MG |

| +-----+-----------------------+--------------------+

| | 66033 | Mycomax 50 | CPS 28X50MG |

| +-----+-----------------------+--------------------+

| | 66032 | Mycomax 50 | CPS 7X50MG |

| +-----+-----------------------+--------------------+

| | 65989 | Mycomax INF. | INF 1X100ML/200 mg |

+------------+-----+-----------------------+--------------------+

| itraconazole | 58871 | Sporanox | CPS 15X100MG |

| +-----+-----------------------+--------------------+

| | 58872 | Sporanox | CPS 28X100MG |

| +-----+-----------------------+--------------------+

| | 58870 | Sporanox | CPS 4X100MG |

| +-----+-----------------------+--------------------+

| | 56067 | Sporanox | SOL 1X150ML/1.5 GM |

+------------+-----+-----------------------+--------------------+

| amphotericin | 44141 | Abelcet | INF 10X10ML/50 mg |

| +-----+-----------------------+--------------------+

| | 44148 | Abelcet | INF 10X10ML/50 mg |

| +-----+-----------------------+--------------------+

| | 44142 | Abelcet | INF 10X20ML/100 mg |

| +-----+-----------------------+--------------------+

| | 44149 | Abelcet | INF 10X20ML/100 mg |

| +-----+-----------------------+--------------------+

| | 01293 | Amphocil 100 mg | INJ SIC 10X100MG |

| +-----+-----------------------+--------------------+

| | 01291 | Amphocil 100 mg | INJ SIC 1X100MG |

| +-----+-----------------------+--------------------+

| | 01295 | Amphocil 50 mg | INJ SIC 10X50MG |

| +-----+-----------------------+--------------------+

| | 01294 | Amphocil 50 mg | INJ SIC 1X50MG |

| +-----+-----------------------+--------------------+

| | 57548 | Amphotericin B SQUIBB | INJ SIC 1X50MG |

+------------+-----+-----------------------+--------------------+

| zidovudine | 86100 | Retrovir | INF CNC5X20ML/200 mg |

| +-----+-----------------------+--------------------+

| | 58860 | Retrovir | SIR 200 ml 50 mg/5 ml |

| +-----+-----------------------+--------------------+

| | 58729 | Retrovir 100 | CPS 100X100MG |

| +-----+-----------------------+--------------------+

| | 58728 | Retrovir 250 | CPS 40X250MG |

| +-----+-----------------------+--------------------+

| | 86100 | Retrovir I.V.pro infus. | INF 50X20ML/200 mg |

+------------+-----+-----------------------+--------------------+

|-triphosphate | 47158 | Generic Epivir | TBL OBD 60X150MG |

| +-----+-----------------------+--------------------+

| | 47159 | Epivir solution peroralni | SOL 1X250ML 100 mg/ML |

| +-----+-----------------------+--------------------+

| | 02085 | Zeffix 100 mg | TBL OBD 28X100ML |

| +-----+-----------------------+--------------------+

| | 02086 | Zeffix 100 mg | TBL OBD 84X100MG |

| +-----+-----------------------+--------------------+

| | 02087 | Zeffix 5 mg/ML | SOL 1X240ML/1.2 G |

+------------+-----+-----------------------+--------------------+

| | + zidovudine 57852 | Combivir | TBL OBD 60 (blister) |

|lamivudin +-----+-----------------------+--------------------+

| | 59221 | Combivir | TBL OBD 60 (the) |

+------------+-----+-----------------------+--------------------+

| didanosine | 57422 | Videx 100 mg | CTB 60X100MG |

| +-----+-----------------------+--------------------+

| | 57423 | Videx 200 mg | CTB 60X150MG |

+------------+-----+-----------------------+--------------------+

| zalcitabine | 66733 | Hivid 0.375 MG | TBL OBD 100 x 0.375 MG |

| +-----+-----------------------+--------------------+

| | 66734 | Hivid 0.75 MG | TBL OBD 100 x 0.75 MG |

+------------+-----+-----------------------+--------------------+

| stavudine | 53209 | Zerit 40 mg | CTB 56X40MG |

+------------+-----+-----------------------+--------------------+

| Abacavir | 58396 | Ziagen | TBL OBD 60X300MG |

+------------+-----+-----------------------+--------------------+

| nevirapine | 5777 | iramune | TBL 60X200MG |

+------------+-----+-----------------------+--------------------+

| efavirenz | 58246 | Stocrin 100 mg | CPS 30X100MG |

| +-----+-----------------------+--------------------+

| | 58245 | Stocrin 50 mg | CPS 30X50MG |

| +-----+-----------------------+--------------------+

| | 59948 | Stocrin | CPS 90X200MG |

+------------+-----+-----------------------+--------------------+

| sakvinavir | 55688 | Invirase | CPS 270X200MG |

+------------+-----+-----------------------+--------------------+

| ritonavir | 57784 | Norvir | CPS 2X84 = 168X100MG |

| +-----+-----------------------+--------------------+

| | 53271 | Norvir solution | SOL 5X90ML 80 mg/ML |

+------------+-----+-----------------------+--------------------+

| indinavir | 44124 | Crixivan 200 | CPS 360X200MG |

| +-----+-----------------------+--------------------+

| | 44126 | Crixivan 400 | CPS 180X400MG |

+------------+-----+-----------------------+--------------------+

| nelfinavir | 59903 | Viracept 250 mg | TBL 180X250MG |

| +-----+-----------------------+--------------------+

| | 59852 | Viracept 25 mg/GM | PLV SUS 1X144GM |

+------------+-----+-----------------------+--------------------+

| ganciclovir | 02064 | Cymevene | SIC INF 1X500MG |

| +-----+-----------------------+--------------------+

| | 59653 | Cymevene 250 mg | CPS 84X250MG |


+------------+-----+-----------------------+--------------------+

| foscarnet | 62698 | Foscavir 24 mg/ML Iv | INF 1X250ML 24 mg/ML |

+------------+-----+-----------------------+--------------------+

| acyclovir | 57068 | AL include aciclovir 200 | TBL 25X200MG |

| +-----+-----------------------+--------------------+

| | 56079 | Include aciclovir AL 400 | TBL 35X400MG |

| +-----+-----------------------+--------------------+

| | 54031 | Provirsan | TBL 30X200MG |

| +-----+-----------------------+--------------------+

| | 54213 | Ranvir 200 | TBL 25X200MG |

| +-----+-----------------------+--------------------+

| | 54216 | Ranvir 400 | TBL 25X400MG |

| +-----+-----------------------+--------------------+

| | 93988 | Virolex | SIC INF 5X250MG |

| +-----+-----------------------+--------------------+

| | 53608 | Xorox 200 mg | TBL 25X200MG |

| +-----+-----------------------+--------------------+

| | 53607 | Xorox 250 mg | SIC INF 5X250MG |

| +-----+-----------------------+--------------------+

| | 53610 | Xorox 400 mg | TBL 60X400MG |

| +-----+-----------------------+--------------------+

| | 53611 | Xorox 800 mg | TBL 35X800MG |

| +-----+-----------------------+--------------------+

| | 64953 | Zovirax 250 mg | INJ SIC 5X250MG |

| +-----+-----------------------+--------------------+

| | 64952 | Zovirax 500 mg | INJ SIC 5X500MG |

| +-----+-----------------------+--------------------+

| | 66010 | Zovirax 800 mg | TBL 35X800MG |

| +-----+-----------------------+--------------------+

| | 88303 | Zovirax | TBL 25X200MG |

| +-----+-----------------------+--------------------+

| | 96448 | Zovirax | TBL 70X400MG |

| +-----+-----------------------+--------------------+

| | 93191 | Zovirax 200 mg/5 ml | SUS 1X125ML |

| +-----+-----------------------+--------------------+

| | 84128 | Yosef 400 | TBL 25X400MG |

| +-----+-----------------------+--------------------+

| | 84127 | Yosef 200 | TBL 25X200MG |

| +-----+-----------------------+--------------------+

| | 93260 | Yosef 250 | INJ SIC 10X250MG |

| +-----+-----------------------+--------------------+

| | 93987 | Virolex | TBL 20X200MG |

| +-----+-----------------------+--------------------+

| | 93990 | Virolex | UNG OPH 1 x 4.5 GM 3% |

| +-----+-----------------------+--------------------+

| | 87911 | Zovirax | UNG OPH 1 4.0 GM |

+------------+-----+-----------------------+--------------------+

| | valaciclovir 53075 | Valtrex | TBL OBD 10X500MG |

| +-----+-----------------------+--------------------+

| | 87205 | Valtrex | TBL OBD 42X500MG |

| +-----+-----------------------+--------------------+

| | 03002 | Valtrex 250 mg | TBL OBD 60X250MG |

| +-----+-----------------------+--------------------+

| | 59947 | Valtrex 250 mg | TBL OBD 60X250MG |

+------------+-----+-----------------------+--------------------+

|-interferon | 59047 | Infergen | INJ 12 x 0.2 ML/9RG |

|alfa +-----+-----------------------+--------------------+

| | 59043 | Infergen | INJ 1 x 0.2 ML/9RG |

| +-----+-----------------------+--------------------+

| | 59046 | Infergen | INJ 6 x 0.2 ML/9RG |

| +-----+-----------------------+--------------------+

| | 59222 | Intron and 10 miles. IU | INJ SIC 1X10MU + SOLV |

| +-----+-----------------------+--------------------+

| | 59228 | Intron and 10 miles. IU | INJ SIC 30X10MU + SOL |

| +-----+-----------------------+--------------------+

| | 59225 | Intron and 10 miles. IU | INJ SIC 6X10MU + SOLV |

| +-----+-----------------------+--------------------+

| | 91639 | Intron and 10 miles. IU | INJ SIC 1X3MU |

| +-----+-----------------------+--------------------+

| | 59226 | Intron and 3 miles. IU | INJ SIC 30X3MU + SOLV |

| +-----+-----------------------+--------------------+

| | 59223 | Intron and 3 miles. IU | INJ SIC 6X3MU + SOLV |

| +-----+-----------------------+--------------------+

| | 54372 | Intron and 3 miles. IU/| INJ 1 x 0.5 ML-the. |

| | | 0.5 ML | |

| +-----+-----------------------+--------------------+

| | 53197 | Intron and 30 miles. IU | INJ SIC 1X30MU |

| +-----+-----------------------+--------------------+

| | 83394 | Intron and 5 miles. IU | INJ SIC 1X5MU + SOLV |

| +-----+-----------------------+--------------------+

| | 59227 | Intron and 5 miles. IU | INJ SIC 30X5MU + SOLV |

| +-----+-----------------------+--------------------+

| | 59224 | Intron and 5 miles. IU | INJ SIC 6X5MU + SOLV |

| +-----+-----------------------+--------------------+

| | 54374 | Intron and 5 miles. IU/| INJ 1 x 0.5 ML-the. |

| | | 0.5 ML | |

| +-----+-----------------------+--------------------+

| | 54375 | INTRON and 5 miles. IU/| INJ 1X1ML-the. |

| | | 0.5 ML | |

| +-----+-----------------------+--------------------+

| | 54402 | Roferon-A 18 MIU/0.6 ML | INJ 3 x 0.6 ML/18MU |

| +-----+-----------------------+--------------------+

| | 89225 | Roferon-A 18MIU/3 ml | INJ 1X3ML/18MU |

| +-----+-----------------------+--------------------+

| | 54400 | Roferon-A 3 MIU/0.5 ML | INJ 5 x 0.5 ML/3MU + PAGE |

| +-----+-----------------------+--------------------+

| | 89224 | Roferon-A 3MIU/1 ml | INJ 1X1ML/3MU |

| +-----+-----------------------+--------------------+

| | 93101 | Wellferon 10MU | INJ 1X1ML/10MU |

| +-----+-----------------------+--------------------+

| | 93100 | Wellferon 3MU | INJ 1X1ML/3MU |

| +-----+-----------------------+--------------------+

| | 56672 | Wellferon 5MU | INJ 1X1ML/5MU |

| +-----+-----------------------+--------------------+

| | 54563 | Intron A3 MIL. IU/| INJ 1 x 0.5 ML + SET. |

| | | 0.5 ML | |

| +-----+-----------------------+--------------------+

| | 54560 | Intron A5 Miles. IU/| INJ 1 x 0.5 ML + SET. |

| | | 0.5 ML | |

| +-----+-----------------------+--------------------+

| | 54561 | Intron A5 Miles. IU/| INJ 1X1ML + SET. |

| | | 0.5 ML | |

| +-----+-----------------------+--------------------+

| | 54474 | Intron a redipen | INJ 1 1.2 ML/60MU |

| | | 4 IU | |

| +-----+-----------------------+--------------------+

| | 54472 | Intron a redipen | INJ 1 1.2 ML/18MU |

| | | 3 IU | |

| +-----+-----------------------+--------------------+

| | 54473 | Intron a redipen | INJ 1 1.2 ML/30MU |

| | | 6 IU | |

+------------+-----+-----------------------+--------------------+

| filgrastim | 69026 | NEUPOGEN | INJ 5X1ML/0.3 MG |

| +-----+-----------------------+--------------------+

| | 57864 | NEUPOGEN | INJ 5 x 1.6 ML |

| +-----+-----------------------+--------------------+

| | 98297 | NEUPOGEN | INJ 5 x 1.6 ML |

| +-----+-----------------------+--------------------+

| | 57863 | NEUPOGEN | INJ 5X1ML |

+------------+-----+-----------------------+--------------------+

| erythropoietin | 57340 | Eprex 1, 000 IU/0.1 ML | INJ 6 x 0.5 ML/5KU + PAGE |

| +-----+-----------------------+--------------------+

| | 57341 | Eprex 1, 000 IU/0.1 ML | INJ 6 x 0.6 ML/6KU + PAGE |

| +-----+-----------------------+--------------------+

| | 57342 | Eprex 1, 000 IU/0.1 ML | INJ 6 x 0.7 ML/7KU + PAGE |

| +-----+-----------------------+--------------------+

| | 57343 | Eprex 1, 000 IU/0.1 ML | INJ 6 x 0.8 ML/8KU + PAGE |

| +-----+-----------------------+--------------------+

| | 57344 | Eprex 1, 000 IU/0.1 ML | INJ 6 x 0.6 ML/9KU + PAGE |

| +-----+-----------------------+--------------------+

| | 85530 | Eprex 1, 000 IU/0.1 ML | INJ 6 x 0.2 ML/3KU + PAGE |

| +-----+-----------------------+--------------------+

| | 85531 | Eprex 1, 000 IU/0.1 ML | INJ 6 x 0.4 ML/purchase + PAGE |

| +-----+-----------------------+--------------------+

| | 85532 | Eprex 1, 000 IU/0.1 ML | INJ 6X1ML/10KU + PAGE |

| +-----+-----------------------+--------------------+

| | 85528 | Eprex 200 IU/0.1 ML | INJ 6 x 0.5 ML/1KU + PAGE |

| +-----+-----------------------+--------------------+

| | 93579 | Eprex 200 IU/0.1 ML | INJ 6X1ML/2KU-the. |

| +-----+-----------------------+--------------------+

| | 85529 | Eprex 400 IU/0.1 ML | INJ 6 x 0.5 ML/2KU + PAGE |

| +-----+-----------------------+--------------------+

| | 02267 | Eprex 40000 | INJ 1X1ML/40KU-the. |

| +-----+-----------------------+--------------------+

| | 64816 | Neorecormon 1000 IU | INJ 6 x 0.2 ML/1KU |

| +-----+-----------------------+--------------------+

| | 58451 | Neorecormon 10000 IU | INJ 6 x 0.6 ML/10KU |

| +-----+-----------------------+--------------------+

| | 64812 | Neorecormon 2000 IU | INJ 6 x 0.2 ML/2KU |

| +-----+-----------------------+--------------------+

| | 58453 | Neorecormon 2000 IU | INJ 6 x 0.6 ML/20KU |

| +-----+-----------------------+--------------------+

| | 64818 | Neorecormon 3000 IU | INJ 6 x 0.2 ML/3KU |

| +-----+-----------------------+--------------------+

| | 06221 | Neorecormon 4000 IU | INJ SOL 6X4000IU |

| +-----+-----------------------+--------------------+

| | 64814 | Neorecormon 500 IU | INJ 6 x 0.2 ML/500UT |

| +-----+-----------------------+--------------------+

| | 58449 | Neorecormon 500 IU | INJ 6 x 0.2 ML/5KU |

| +-----+-----------------------+--------------------+

| | 58686 | Neorecormon Multidose | INJ SIC 1X100KU + SOL |

| | | 100000 | |

| +-----+-----------------------+--------------------+


| | 58685 | Neorecormon Multidose | INJ SIC 1X50KU + SOLV |

| | | 50000 | |

| +-----+-----------------------+--------------------+

| | 58688 | Neorecormon for recopen | INJ SIC 3X10KU + SOLV |

| | | 10000 | |

| +-----+-----------------------+--------------------+

| | 58744 | Neorecormon for recopen | INJ SIC 3X20KU + SOLV |

| | | 20000 | |

| +-----+-----------------------+--------------------+

| | 45355 | Recormon with 10000 | INJ SIC 5X10KU + STR. |

| +-----+-----------------------+--------------------+

| | 45354 | Recormon with 5000 | INJ SIC 5X5KU + STR. |

+------------+-----+-----------------------+--------------------+



Č. 7



List of inpatient health care facility-center for treatment of burns

+--+--------+----------------------------+--------------+-----------------------+

| # | CORPORATE ID | The name of the post operative care | Head Office | The workplace |

+--+--------+----------------------------+--------------+-----------------------+

| # 1 | 00064173 | Royal University Hospital | Prague 10 | Department of burns |

| | | Vinohrady | | medicine |

+--+--------+----------------------------+--------------+-----------------------+

| 2 | 00843989 | University Hospital | Ostrava-Poruba | Burns Center |

| | | first | ||

+--+--------+----------------------------+--------------+-----------------------+

| # 3 | 65269705 | University Hospital Brno | Brno | Centre (clinic) |

| | | | | Burns and |

| | | | | Reconstructive surgery |

+--+--------+----------------------------+--------------+-----------------------+



Č. 8



List of inpatient health care facility-center for the treatment of cystic

Fibrosis

+--+--------+----------------------------+--------------+-----------------------+

| # | CORPORATE ID | The name of the post operative care | Head Office | The workplace |

+--+--------+----------------------------+--------------+-----------------------+

| # 1 | 00064203 | University Hospital | Prague 5 | 2. Department of Pediatrics, |

| | | in motol | | THORN |

+--+--------+----------------------------+--------------+-----------------------+

| 2 | 65269705 | University Hospital Brno | Brno | Infectious DFN clinic |

+--+--------+----------------------------+--------------+-----------------------+

| # 3 | 00179906 | Faculty hospital Hradec | Hradec Králové | The Department of Pediatrics |

| | | Kings | ||

+--+--------+----------------------------+--------------+-----------------------+

| 4 | 00669806 | Faculty hospital Pilsen | Pilsen | The Department of Pediatrics |

+--+--------+----------------------------+--------------+-----------------------+

| 5. | 00098892 | University Hospital Olomouc | Olomouc | The Department of Pediatrics |

| | | | TRN clinic | |

+--+--------+----------------------------+--------------+-----------------------+



Č. 9



List of medicinal products for the treatment of cystic fibrosis

+-----------+-----+-------------------------------------+-------------------+

| ATC | Code | The name | The add-in |

+-----------+-----+-------------------------------------+-------------------+

| ciprofloxa | 87104 | Cifloxinal | TBL OBD 10X250MG |

|cin +-----+-------------------------------------+-------------------+

| | 53715 | Cifloxinal | TBL OBD 200X250MG |

| +-----+-------------------------------------+-------------------+

| | 87105 | Cifloxinal | TBL OBD 20X250MG |

| +-----+-------------------------------------+-------------------+

| | 53201 | Ciphin 250 | TBL OBD 10X250MG |

| +-----+-------------------------------------+-------------------+

| | 53202 | Ciphin 500 | TBL OBD 10X500MG |

| +-----+-------------------------------------+-------------------+

| | 53203 | Ciphin 750 | TBL OBD 10X750MG |

| +-----+-------------------------------------+-------------------+

| | 53922 | Ciphin for infusion. 200 mg/100 ML | INF 1X100ML/200 mg |

| +-----+-------------------------------------+-------------------+

| | 53921 | Ciphin for infusione 100 mg/50 ML | INF 1X50ML/100 mg |

| +-----+-------------------------------------+-------------------+

| | 56830 | Ciplox 200 mg/100 ml | INF 1X100ML (plastic) |

| +-----+-------------------------------------+-------------------+

| 44988 | | Ciplox 250 | TBL OBD 10X250MG |

| +-----+-------------------------------------+-------------------+

| | 44989 | Ciplox 250 | TBL OBD 50X250MG |

| +-----+-------------------------------------+-------------------+

| | 44985 | Ciplox 500 | TBL OBD 10X500MG |

| +-----+-------------------------------------+-------------------+

| | 44986 | Ciplox 500 | TBL OBD 50X500MG |

| +-----+-------------------------------------+-------------------+

| | 96040 | Ciprinol 100 mg/10 ml | INF 5X10ML/100 mg |

| +-----+-------------------------------------+-------------------+

| | 59829 | Ciprinol is 100 mg/50 ml | INF 1X50ML/100 mg |

| +-----+-------------------------------------+-------------------+

| | 59830 | Ciprinol 200 mg/100 ml | INF 1X100ML/200 mg |

| +-----+-------------------------------------+-------------------+

| | 94453 | Ciprinol 250 | TBL OBD 10X250MG |

| +-----+-------------------------------------+-------------------+

| | 96039 | Ciprinol 500 | TBL OBD 10X500MG |

| +-----+-------------------------------------+-------------------+

| | 86636 | Ciprobay 100 | INF 5X50ML/100 mg |

| +-----+-------------------------------------+-------------------+

| | 86637 | Ciprobay 200 | INF 5X100ML/200 mg |

| +-----+-------------------------------------+-------------------+

| | 91155 | Ciprobay 250 | TBL OBD 10X250MG |

| +-----+-------------------------------------+-------------------+

| | 91156 | Ciprobay 500 | TBL OBD 10X500MG |

| +-----+-------------------------------------+-------------------+

| | 69195 | Ciprobay 250 | TBL OBD 10X250MG |

| +-----+-------------------------------------+-------------------+

| | 69196 | Ciprobay 500 | TBL OBD 10X500MG |

| +-----+-------------------------------------+-------------------+

| | 64698 | Quintor 250 mg | TBL OBD 10X250MG |

| +-----+-------------------------------------+-------------------+

| | 80539 | Quintor 250 mg | TBL OBD 50X250MG |

| +-----+-------------------------------------+-------------------+

| | 64699 | Quintor 500 mg | TBL OBD 10X500MG |

| +-----+-------------------------------------+-------------------+

| | 80540 | Quintor 500 mg | TBL OBD 20X500MG |

+-----------+-----+-------------------------------------+-------------------+

| fluconazole | 58431 | Diflazon | INF 1X100ML/200 mg |

| +-----+-------------------------------------+-------------------+

| | 59787 | Diflazon 100 | CPS 28X100MG |

| +-----+-------------------------------------+-------------------+

| | 59788 | Diflazon 150 | CPS 1X150MG |

| +-----+-------------------------------------+-------------------+

| | 59790 | Diflazon 200 | CPS 20X200MG |

| +-----+-------------------------------------+-------------------+

| | 59789 | Diflazon 200 | CPS 7X200MG |

| +-----+-------------------------------------+-------------------+

| | 59786 | Diflazon 50 | CPS 7X50MG |

| +-----+-------------------------------------+-------------------+

| | 64942 | Diflucan 100 mg | CPS 28X100MG |

| +-----+-------------------------------------+-------------------+

| | 64949 | Diflucan 200 mg/5 ml | PLV SUS 1X35ML |

| +-----+-------------------------------------+-------------------+

| | 64940 | Diflucan 50 mg | CPS 7X50MG |

| +-----+-------------------------------------+-------------------+

| | 64950 | Diflucan 50 mg/5 ml | PLV SUS 1X35ML |

| +-----+-------------------------------------+-------------------+

| | 64946 | Diflucan Iv | INF 1X100ML 2 mg/ML |

| +-----+-------------------------------------+-------------------+

| | 53917 | Fluconazol 150-Slovakofarma | CPS 1X150MG |

| +-----+-------------------------------------+-------------------+

| | 53918 | Fluconazol 150-Slovakofarma | CPS 2X150MG |

| +-----+-------------------------------------+-------------------+

| | 53915 | Fluconazol 50-Slovakofarma | CPS 10X50MG |

| +-----+-------------------------------------+-------------------+

| | 55397 | Fluconazol 50-Slovakofarma | CPS 14X50MG |

| +-----+-------------------------------------+-------------------+

| | 53916 | Fluconazol 50-Slovakofarma | CPS 20X50MG |

| +-----+-------------------------------------+-------------------+

| | 55396 | Fluconazol 50-Slovakofarma | CPS 7X50MG |

| +-----+-------------------------------------+-------------------+

| | 46979 | Fluconazol-Slovakofarma for inf | INF 1X100ML/200 mg |

| +-----+-------------------------------------+-------------------+

| | 66036 | Mycomax 100 | CPS 28X100MG |

| +-----+-------------------------------------+-------------------+

| | 66037 | Mycomax 100 | CPS 7X100MG |

| +-----+-------------------------------------+-------------------+

| | 66039 | Mycomax 150 | CPS 1X150MG |

| +-----+-------------------------------------+-------------------+


| | 66033 | Mycomax 50 | CPS 28X50MG |

| +-----+-------------------------------------+-------------------+

| | 66032 | Mycomax 50 | CPS 7X50MG |

| +-----+-------------------------------------+-------------------+

| | 65989 | Mycomax inf | INF 1X100ML/200 mg |

| +-----+-------------------------------------+-------------------+

| | 66031 | Sir Mycomax | SIR 1X100ML/500 mg |

| +-----+-------------------------------------+-------------------+

| | 59872 | Mycosyst | INF 10X100ML 2 mg/ML |

| +-----+-------------------------------------+-------------------+

| | 59871 | Mycosyst | INF 1X100ML 2 mg/ML |

| +-----+-------------------------------------+-------------------+

| | 59874 | Mycosyst 100 mg | CPS 28X100MG |

| +-----+-------------------------------------+-------------------+

| | 59875 | Mycosyst 150 mg | CPS 1X150MG |

| +-----+-------------------------------------+-------------------+

| | 59876 | Mycosyst 150 mg | CPS 2X150MG |

| +-----+-------------------------------------+-------------------+

| | 10743 | Mycosyst 150 mg | CPS 4X150MG |

| +-----+-------------------------------------+-------------------+

| | 59873 | Mycosyst 50 mg | CPS 7X50MG |

+-----------+-----+-------------------------------------+-------------------+

| fats | 53321 | Advera-vanilkova prichut | SOL 1X237ML |

|sacharidy, +-----+-------------------------------------+-------------------+

proteins, 44012 | | | Enrich cokoladova prichut | SOL 1X250ML |

|minerály, +-----+-------------------------------------+-------------------+

| | 75585 vitamins | Enrich vanilkova prichut | SOL 1X250ML |

|kombinace +-----+-------------------------------------+-------------------+

| | 83371 | Ensure plus | SOL 1X250ML |

| +-----+-------------------------------------+-------------------+

| | 8372 | Ensure plus | SOL 1X500ML |

| +-----+-------------------------------------+-------------------+

| | 53447 | Ensure plus hn | SOL 1X200ML |

| +-----+-------------------------------------+-------------------+

| | 86109 | Ensure vanilla | SOL 1X250ML |

| +-----+-------------------------------------+-------------------+

| | 59109 | Fresubin 750 MCT | SOL 12X500ML |

| +-----+-------------------------------------+-------------------+

| | 87173 | Fresubin 750 MCT | SOL 1X500ML |

| +-----+-------------------------------------+-------------------+

| | 53322 | Glucerna RTH-vanilkova prichut | SOL 1X1000ML |

| +-----+-------------------------------------+-------------------+

| | 53323 | Glucerna RTH-vanilkova prichut | SOL 1X500ML |

| +-----+-------------------------------------+-------------------+

| | 53318 | Glucerna-vanilkova prichut | SOL 1X237ML |

| +-----+-------------------------------------+-------------------+

| | 56245 | Inkodiet fibre | POR SUS 1X500ML |

| +-----+-------------------------------------+-------------------+

| | 56244 | Inkodiet standard | POR SUS 12X500ML |

| +-----+-------------------------------------+-------------------+

| | 56246 | Sonde Inkopeptid | POR SUS 12X500ML |

| +-----+-------------------------------------+-------------------+

| | 59688 | Isosource MCT himbeer | PLV 6X80GM |

| +-----+-------------------------------------+-------------------+

| | 59685 | Isosource MCT orange | PLV 6X80GM |

| +-----+-------------------------------------+-------------------+

| | 59683 | Isosource MCT oxtail | PLV 6X80GM |

| +-----+-------------------------------------+-------------------+

| | 59681 | Isosource MCT vanille | PLV 6X80GM |

| +-----+-------------------------------------+-------------------+

| | 86766 | Unless with vanilla prichuti | SOL 1X237ML |

| +-----+-------------------------------------+-------------------+

| | 75091 | Standard Nutrodrip cokolada | SOL 12X500ML |

| +-----+-------------------------------------+-------------------+

| | 75090 | Nutrodrip standard kava | SOL 12X500ML |

| +-----+-------------------------------------+-------------------+

| | 94090 | Nutrodrip standard neutral | SOL 12X500ML |

| +-----+-------------------------------------+-------------------+

| | 94091 | Nutrodrip standard vanilla | SOL 12X500ML |

| +-----+-------------------------------------+-------------------+

| | 59044 | Osmolite | SOL 1X1000ML |

| +-----+-------------------------------------+-------------------+

| | 59045 | Osmolite | SOL 1X1500ML |

| +-----+-------------------------------------+-------------------+

| | 75586 | Osmolite | SOL 1X250ML |

| +-----+-------------------------------------+-------------------+

| | 75587 | Osmolite | SOL 1X500ML |

| +-----+-------------------------------------+-------------------+

| | 58677 | Paediasure | SOL 1X250ML |

| +-----+-------------------------------------+-------------------+

| | 59041 | Perative | SOL 1X1000ML |

| +-----+-------------------------------------+-------------------+

| | 86783 | Perative | SOL 1 227.2 ML |

| +-----+-------------------------------------+-------------------+

| | 57432 | Pregestimil | PLV 1X450GM |

| +-----+-------------------------------------+-------------------+

| | 57433 | Pregestimil | PLV 1X450GM |

| +-----+-------------------------------------+-------------------+

| | 84477 | Pulmocare | SOL 1X250ML (AL) |

| +-----+-------------------------------------+-------------------+

| | 58131 | Pulmocare | SOL 1X500ML (PP) |

| +-----+-------------------------------------+-------------------+

| | 86784 | Suplena | SOL 1 227.2 ML |

| +-----+-------------------------------------+-------------------+

| | 57357 | Survimed OPD neutral | SOL 12X500ML |

| +-----+-------------------------------------+-------------------+

| | 12470 | Survimed OPD neutral | SOL 1X500ML |

+-----------+-----+-------------------------------------+-------------------+



Č. 10



List of inpatient health care facility-workplaces for the treatment

oncologically ill children

+--+--------+----------------------------+--------------+------------------------+

| # | CORPORATE ID | The name of the post operative care | Head Office | The workplace |

+--+--------+----------------------------+--------------+----------------------- |

| # 1 | 00064203 | Teaching hospital in motol | Prague 5 | Department of paediatric Oncology |

+--+--------+----------------------------+--------------+----------------------- |

| 2 | 65269705 | University Hospital Brno | Brno | The children's Department of onkologi |

+--+--------+----------------------------+--------------+------------------------+



Č. 11



List of medicinal products for the treatment of sick children with cancer "

+---------------+-----+-------------------------------------+--------------------+

| The active substance | Code | The name | The add-in |

+---------------+-----+-------------------------------------+--------------------+

| erythropoietin | 85530 | Eprex 1000 IU/0.1 ML | INJ 6 x 0.2 ML/3KU + PAGE |

| +-----+-------------------------------------+--------------------+

| | 85531 | Eprex 1000 IU/0.1 ML | INJ 6 x 0.4 ML/purchase + PAGE |

| +-----+-------------------------------------+--------------------+

| | 85532 | Eprex 1000 IU/0.1 ML | INJ 6X1ML/10KU + PAGE |

| +-----+-------------------------------------+--------------------+

| | 85528 | Eprex 200 IU/0.1 ML | INJ 6 x 0.5 ML/1KU + PAGE |

| +-----+-------------------------------------+--------------------+

| | 93579 | Eprex 200 IU/0.1 ML | INJ 6X1ML/2KU-the. |

| +-----+-------------------------------------+--------------------+

| | 85529 | Eprex 400 IU/0.1 ML | INJ 6 x 0.5 ML/2KU + PAGE |

| +-----+-------------------------------------+--------------------+

| | 64816 | Neorecormon 1000 IU | INJ 6 x 0.2 ML/1KU |

| +-----+-------------------------------------+--------------------+

| | 64812 | Neorecormon 2000 IU | INJ 6 x 0.2 ML/2KU |

| +-----+-------------------------------------+--------------------+

| | 64818 | Neorecormon 3000 IU | INJ 6 x 0.2 ML/3KU |

| +-----+-------------------------------------+--------------------+

| | 64814 | Neorecormon 500 IU | INJ 6 x 0.2 ML/500UT |

| +-----+-------------------------------------+--------------------+

| | 58685 | Neorecormon 500 IU multidose 50000 | INJ SIC 1X50KU + SOL |

| +-----+-------------------------------------+--------------------+

| | 45355 | Recormon with 10000 | INJ SIC 5X10KU + PAGE |

| +-----+-------------------------------------+--------------------+

| | 45354 | Recormon with 5000 | INJ SIC 5X5KU + PAGE |

+---------------+-----+-------------------------------------+--------------------+

interferon-alpha | | 59222 | Intron and 10 miles. IU | INJ SIC 1X10MU + SOLV |

| +-----+-------------------------------------+--------------------+

| | 83393 | Intron and 3 miles. IU | INJ SIC 1X3MU + SOLV |

| +-----+-------------------------------------+--------------------+

| 54563 | lntron | and 3 miles. IU/0.5ML | INJ 1 x 0.5 ML + SET. |

| +-----+-------------------------------------+--------------------+


| 54372 | lntron | and 3 miles. IU/0.5ML | INJ 1 x 0.5 ML-the. |

| +-----+-------------------------------------+--------------------+

| 83394 | lntron | and 5 miles. IU | INJ SIC 1X5MU + SOLV |

| +-----+-------------------------------------+--------------------+

| 54560 | lntron | and 5 miles. IU/0.5ML | INJ 1 x 0.5 ML + SET |

| +-----+-------------------------------------+--------------------+

| 54374 | lntron | and 5 miles. IU/0.5ML | INJ 1 x 0.5 ML-the. |

| +-----+-------------------------------------+--------------------+

| 54561 | lntron | and 5 miles. IU/0.5ML | INJ 1X1ML + SET. |

| +-----+-------------------------------------+--------------------+

| | 54375 | lntron and 5 miles. IU/0.5ML | INJ 1X1ML-the. |

| +-----+-------------------------------------+--------------------+

| | lntron and redipen 54474 | 10 miles. IU | INJ 1 1.2 ML/60MU |

| +-----+-------------------------------------+--------------------+

| 54472 | lntron | and redipen 3 miles. IU | INJ 1 1.2 ML/18MU |

| +-----+-------------------------------------+--------------------+

| | lntron and redipen 54473 | 5 MIL. IU | INJ 1 1.2 ML/30MU |

| +-----+-------------------------------------+--------------------+

| | 54402 | Roferon-A 18MIU/0.6 ML | INJ 3 x 0.6 ML/18MU |

| +-----+-------------------------------------+--------------------+

| | 89225 | Roferon-A 18MIU/3 ml | INJ 1X3ML/18MU |

| +-----+-------------------------------------+--------------------+

| | 54400 | Roferon-A 3MIU/0.5 ML | INJ 5 x 0.5 ML/3MU + PAGE |

| +-----+-------------------------------------+--------------------+

| | 93101 | Wellferon 10MU | INJ 1X1ML/10MU |

| +-----+-------------------------------------+--------------------+

| | 93100 | Wellferon 3MU | INJ 1X1ML/3MU |

| +-----+-------------------------------------+--------------------+

| | 56672 | Wellferon 5MU | INJ 1X1ML/5MU |

+---------------+-----+-------------------------------------+--------------------+

| amifostine | 12457 | Ethyol | INJ SIC 3X500MG |

+---------------+-----+-------------------------------------+--------------------+

| amphotericin | 44141 | Abelcet | INF 10X10ML/50 mg |

| +-----+-------------------------------------+--------------------+

| | 44148 | Abelcet | INF 10X10ML/50 mg |

| +-----+-------------------------------------+--------------------+

| | 44142 | Abelcet | INF 10X20ML/100 mg |

| +-----+-------------------------------------+--------------------+

| | 44149 | Abelcet | INF 10X20ML/100 mg |

| +-----+-------------------------------------+--------------------+

| | 01293 | Amphocil 100 mg | INJ SIC 10X100MG |

| +-----+-------------------------------------+--------------------+

| | 01291 | Amphocil 100 mg | INJ SIC 1X100MG |

| +-----+-------------------------------------+--------------------+

| | 01295 | Amphocil 50 mg | INJ SIC 10X50MG |

| +-----+-------------------------------------+--------------------+

| | 01294 | Amphocil 50 mg | INJ SIC 1X50MG |

+---------------+-----+-------------------------------------+--------------------+



1) Decree No. 134/1998 Coll. issuing the list of medical procedures

with point values, as amended by Decree No 55/2000 Coll., Decree No.

135/2000 Coll. and Decree No. 452/2000 Sb.



2) Article. (II) Act No. 458/2000 Coll., amending Act No. 48/1997 Coll.,

on public health insurance and amending and supplementing certain

related laws, as amended. Annex 1, point B)

1. Government Regulation No. 484/2000 Coll., laying down the point values and

the amount of the reimbursement of health care paid for by public health insurance for

1. half of the year 2001.



3) Article. (II) Act No. 458/2000 Coll., section 2 (2). 7 (b). (e)) Government Regulation No.

487/2000 Sb.



4) Article. (II) Act No. 458/2000 Coll., section 2 (2). 7 (b). I) Government Regulation No.

487/2000 Sb.



5) Article. (II) Act No. 458/2000 Coll., Appendix 2, point (B)) 1. Government Regulation

No 487/2000 Sb.



6) Article. (II) Act No. 458/2000 Coll., section 4, paragraph 4. 2 Government Regulation No. 484/2000

SB.



7) Article. (II) Act No. 458/2000 Coll., § 5 para. 2 Government Regulation No. 484/2000

SB.



8) § 40 paragraph 2. 2 of Act No. 48/1997 Coll.



9) Article. (II) Act No. 458/2000 Coll., section 6 (a). (b)) Government Regulation No.

487/2000 Sb.

Related Laws